cyclosporine has been researched along with Diabetes Mellitus in 203 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 53 (26.11) | 18.2507 |
| 2000's | 87 (42.86) | 29.6817 |
| 2010's | 56 (27.59) | 24.3611 |
| 2020's | 7 (3.45) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, J; Liu, Y; Wang, R; Wang, Z; Zhang, Y | 1 |
| Yang, K; Zhang, B; Zhang, M; Zhang, Y; Zhao, Q | 1 |
| Bohley, M; Braunger, BM; Dillinger, AE; Goepferich, A; Tamm, ER | 1 |
| Akgun, AO; Keven, K; Sengul, S; Soypacaci, Z | 1 |
| Ozdem, S; Sari, R; Suleymanlar, G; Yilmaz, N | 1 |
| Basu, RC; Gan, SH; Guad, RM; Liew, CSL; Taylor-Robinson, AW; Wan Md Adnan, WAH; Wu, YS; Zaharan, NL | 1 |
| Can, C; Kun-Ming, P; Qian-Zhou, L; Qing, X; Wei, W; Xiao-Yu, L | 1 |
| Ciałkowska-Rysz, A; Franczyk, B; Gluba-Brzózka, A; Radek, M; Rysz, J | 1 |
| Abramowicz, D; Broeders, N; Budde, K; Kianda, M; Kuypers, DRJ; Rath, T; Weekers, L; Wissing, KM; Witzke, O | 1 |
| Dutz, J; Evans, M; Kirchhof, M; Miliszewski, M; Papp, A; Sikora, S; Song, D | 1 |
| Arns, W; Budde, K; Duerr, M; Eisenberger, U; Guba, M; Hauser, IA; Heller, K; Jacobi, J; Kliem, V; Lehner, F; Mühlfeld, A; Paulus, EM; Porstner, M; Reinke, P; Sommerer, C; Stahl, R; Suwelack, B; Vogt, B; Witzke, O; Wüthrich, RP; Zeier, M | 1 |
| Antoniadis, N; Fouzas, I; Imvrios, G; Miserlis, G; Solonaki, F; Tranda, A; Zolota, A | 1 |
| Kream, RM; Ming, Y; Stefano, GB; Zhuang, Q | 1 |
| Ahn, KJ; Choe, YB; Hong, JR; Lee, YW | 1 |
| Alexandrov, K; Cui, Z; Edwardraja, S; Ely, F; Guo, Z; Johnston, WA; Retamal Lantadilla, I; Ungerer, JPJ; Vickers, C; Walden, P; Whitfield, J; Wijker, E | 1 |
| Duvoux, C; Firpi, R; Grazi, GL; Levy, G; Renner, E; Villamil, F | 1 |
| Alves, R; Baptista, C; Bastos, M; Cotovio, P; Macário, F; Mota, A; Neves, M; Rodrigues, L | 1 |
| Akpek, EK; Smith, RA | 1 |
| Gluud, C; Iversen, M; Møller, CH; Penninga, EI; Penninga, L; Steinbrüchel, DA | 1 |
| Choi, JY; Kwon, OJ | 1 |
| Berhoune, A; Boukni, H; Chettouh, H; Mokhtari, N; Yargui, L | 1 |
| Croy, R; First, MR; Fitzsimmons, WE; Holman, J; Meier-Kriesche, HU; Silva, HT; Yang, HC | 1 |
| Briggs, AH; Johnston, K; Kalsekar, A; L'Italien, GJ; Levy, AR; MacLean, JR; Schnitzler, MA; Yuan, Y | 1 |
| Borda, B; Kemény, E; Keresztes, C; Kubik, A; Lázár, G; Lengyel, C; Ottlakán, A; Várkonyi, T | 1 |
| Eriksson, JW; Pereira, MJ; Svensson, MK | 1 |
| Kirby, B; Ryan, C | 1 |
| Leach, SB; Nafe, LA | 1 |
| Montero, N; Pascual, J | 1 |
| Arnon, R; Goldis, M; Regelmann, MO | 1 |
| Gupta, KL; Kohli, HS; Kumar, S; Kumar, V; Rajkumar, V; Ramachandran, R; Rao, N; Rathi, M; Sakhuja, V; Sharma, A | 1 |
| Borda, B; Hódi, Z; Kemény, É; Lázár, G; Lengyel, C; Szabó, V; Szederkényi, E; Várkonyi, T | 1 |
| Aleksiejuk, P; Banki, K; Bonilla, E; Francis, L; Landas, SK; Liu, Y; Marchena-Mendez, I; Oaks, Z; Patel, J; Perl, A; Yu, J | 1 |
| Domanski, L; Dziedziejko, V; Maciejewska-Karlowska, A; Pawlik, A; Romanowski, M; Safranow, K; Sawczuk, M | 1 |
| Abraham, G; Ali, AA; Mathew, M; Mehra, N; Nagarajan, P; Ramachandran, A; Reddy, PP; Reddy, YN; Sundaram, V | 1 |
| Chen, X; Fan, J; Gao, J; Gao, X; He, S; Huang, X; Liang, J; Lv, C; Sun, Q; Wang, T; Xue, M; Yu, M; Zhang, Y; Zhou, J | 1 |
| Dabrowska-Zamojcin, E; Domanski, L; Dziedziejko, V; Maciejewska-Karlowska, A; Pawlik, A; Romanowski, M; Safranow, K; Sawczuk, M | 1 |
| Akin, EB; Barlas, S; Basturk, T; Celik, V; Ecder, T; Koc, Y; Sakaci, T; Sinangil, A | 1 |
| Axelrod, D; Brennan, DC; Chen, J; Dharnidharka, VR; Lentine, KL; Schechtman, KB; Schnitzler, MA; Segev, DL; Zheng, J | 1 |
| Chakkera, HA; Kaplan, B; Kudva, Y | 1 |
| Camargo, JL; Cavagnolli, G; Pimentel, AL | 1 |
| Arenberger, P; Cetkovska, P; Dolezal, T; Fialova, J; Gkalpakiotis, S; Jircikova, J; Kojanova, M | 1 |
| Banas, M; Hoffmann, U; Krüger, B | 1 |
| Cibrik, D; Luan, FL; Miles, CD; Norman, S; Ojo, AO; Schaubel, DE; Zhang, H | 1 |
| El-Agroudy, AE; El-Baz, M; El-Dahshan, K; Ghoneim, MA; Mahmoud, K; Shokeir, AA | 1 |
| Chiang, GS; Liew, A; Vathsala, A | 1 |
| Fujii, N; Ichikawa, Y; Kato, T; Kishikawa, H; Kobayashi, Y; Nishimura, K; Takahara, S | 1 |
| Calmus, Y; Deray, G; Dumortier, J; Duvoux, C; Janus, N; Karie-Guigues, S; Launay-Vacher, V; Lorho, R; Pageaux, GP; Saliba, F | 1 |
| Huh, W; Joh, JW; Kim, B; Kim, DJ; Kim, SJ; Kim, YG; Lee, JE; Lee, YJ; Oh, HY | 1 |
| Ghafari, A; Masoumi, R; Moghaddasi, S; Nafisi, R; Nogh, H; Nouri-Majalan, N | 1 |
| Cho, JH; Kim, JW; Lee, SH; Park, HS; Sun, C; Yang, CW; Yang, JH; Yoon, KH | 1 |
| Cardoso, BD; Garcia, VD; Gnatta, D; Heineck, I; Keitel, E; Michel, K; Rodrigues, AP | 1 |
| Ahn, CW; Cha, BS; Jeong, SH; Kang, ES; Kim, CH; Kim, I; Kim, YS; Ko, SJ; Lee, HC; Rim, JH; Yim, YS | 1 |
| Chrzanowska, M; Duda, G; Głyda, M; Kamińska, J; Makowska, E | 1 |
| Cui, SH; Li, F; Liu, S; Luo, B; Sun, HC; Sun, JB; Xin, MJ | 1 |
| Hashimoto, YK; Horike, N; Takemori, H; Tamura, M; Uebi, T | 1 |
| Erbay, B; Ergün, I; Karabulut, HG; Keven, K; Kurultak, I; Sengül, S; Soypacaci, Z | 1 |
| Luan, FL; Ojo, AO; Steffick, DE | 1 |
| Brennan, DC; Flore, MC; Machnicki, G; Woodward, RS | 1 |
| Block, A; Bresnahan, B; Campistol, J; Duan, T; Durrbach, A; Glicklich, A; Grinyó, J; Gujrathi, S; Lang, P; Larsen, CP; Mancilla-Urrea, E; Neumayer, HH; Pestana, JM; Vanrenterghem, Y; Vincenti, F | 1 |
| Bizollon, T; Blanc, AS; Di Giambattista, F; Dumortier, J; Durand, F; Duvoux, C; Hardwigsen, J; Lorho, R; Pageaux, GP | 1 |
| Borda, B; Eller, J; Hódi, Z; Lázár, G; Lengyel, C; Marofka, F; Morvay, Z; Szabó, V; Szederkényi, E; Szenohradszky, P; Takács, T | 1 |
| Catanzaro, OL; Labal, ES; Lauria, LC; Obregon, P; Rodriguez, RR | 1 |
| Crespo, M; Galeano, C; Pascual, J; Royuela, A; Zamora, J | 1 |
| Brown, R; Burke, GW; Chen, L; Ciancio, G; Gaynor, JJ; Guerra, G; Hanson, L; Kupin, W; Livingstone, AS; Roth, D; Ruiz, P; Sageshima, J; Tueros, L; Zarak, A | 1 |
| Bjerre, M; Carstens, J; Juhl, C; Jørgensen, KA; Møller, N; Rungby, J; Øzbay, LA | 1 |
| Akhlaghi, F; Amundsen, R; Asberg, A; Dostalek, M; Falck, P; Gohh, RY; Mendonza, AE | 1 |
| Becker, JU; Bröcker, V; Gwinner, W; Haller, H; Hiss, M; Kreipe, HH; Mengel, M; Scheffner, I; Scherer, R; Schubert, V; Schwarz, A | 1 |
| de Mare-Bredemeijer, EL; Metselaar, HJ | 1 |
| Chen, CH; Chien, YS; Chu, SH; Lee, PC; Lian, JD; Loong, CC; Tian, YF; Tsai, CS; Wu, MS | 1 |
| Auyanet, I; Batista, F; Oppenheimer, F; Torregrosa, JV | 1 |
| Rath, T | 1 |
| Ertorer, ME; Gokcel, A; Kocak, R; Savaş, L | 1 |
| Ducobu, J | 1 |
| Castroagudin, JF; Conde, R; Delgado, M; González-Quintela, A; Mella, C; Otero, E; Padin, E; Segade, FR; Tomé, S; Varo, E | 1 |
| Corless, CL; Olyaei, AJ; Rabkin, JM; Rosen, HR | 1 |
| Colak, T; Demirbas, A; Dosemeci, L; Erdoğan, O; Gurkan, A; Tuncer, M; Yakupoglu, G | 1 |
| Forsythe, JL; Oniscu, GC; Wayman, MR; Whitworth, CE | 1 |
| Boucher, A; Dandavino, R; Lauzon, L; Masse, M; Morin, M | 1 |
| Miller, LW | 1 |
| Finegood, DT; Geng Hao, E; Kneteman, NM; Lakey, JR; Rajotte, RV; Shapiro, AM | 1 |
| Afonso, A; Cardoso, J; Chaveiro, MA; Vieira, R | 1 |
| Gradowska, L; Paczek, L; Pilecki, T; Senatorski, G; Wyzgał, J; Zegarska, J | 1 |
| Booth, JC; Jindal, RM; Joseph, JT | 1 |
| Kemper, MJ; Laube, GF; Miozzari, M; Neuhaus, TJ; Spartà, G | 1 |
| Burke, JT; Campistol, JM; Legendre, C; Squifflet, JP | 1 |
| Baty, J; Brennan, DC; Haider, S; Lopez-Rocafort, L; Lowell, JA; Schnitzler, MA; Woodward, RS; Woodworth, TG | 1 |
| Egeland, T; Hagen, M; Hartmann, A; Hjelmesaeth, J; Jenssen, T | 1 |
| Boots, JM; Christiaans, MH; van Duijnhoven, EM; van Hooff, JP | 1 |
| Lima, AS; Rego, LO; T D Correia, MI | 1 |
| Bailey, LL; Chinnock, RE; Fitts, JA; Hathout, EH; Johnston, JK; Mace, JW; Razzouk, AJ | 1 |
| Alvarez, A; Cobo, M; González-Posada, J; Hernández, D; Jiménez, A; Lorenzo, V; Oppenheimer, F; Torregrosa, V; Torres, A | 1 |
| Cienfuegos, JA; Herrero, JI; Pardo, F; Prieto, J; Quiroga, J; Rotellar, F; Sangro, B | 1 |
| Hollomby, DJ; House, A; Jevnikar, AM; Muirhead, N | 1 |
| Goto, N; Haba, T; Inagaki, A; Itatsu, T; Kakiya, S; Katayama, A; Kobayashi, T; Matsuoka, S; Nakao, A; Ohta, K; Okajima, Y; Sato, T; Suga, H; Taguchi, S; Tominaga, Y; Uchida, K; Ueki, T | 1 |
| Burke, GW; Ciancio, G; Gaynor, JJ; Kupin, W; Mattiazzi, A; Miller, J; Nicolas, M; Rosen, A; Roth, D; Ruiz, P | 1 |
| Hattori, R; Hoshinaga, K; Ishibashi, M; Nishioka, T; Ohshima, S; Ono, Y; Yoshimura, N | 1 |
| Chan, MC; Hunt, SA; Kwok, BW; Robbins, RC; Shiba, N; Valantine, HA | 1 |
| Schulak, JA | 1 |
| Balshaw, R; Heisel, O; Heisel, R; Keown, P | 1 |
| Akalin, E; Ames, S; Bromberg, JS; Doan, Y; Emre, S; Fishbein, T; Florman, S; Gondolesi, GE; Krieger, N; Paramesh, AS; Roayaie, S; Schwartz, ME | 1 |
| Copstein, LA; Gonçalves, LF; Manfro, RC; Zelmanovitz, T | 1 |
| Jabur, P; Malafronte, P; Miorin, LA; Sens, YA; Silva, VD; Souza, JF | 1 |
| Boillot, O; Grazi, GL; Klintmalm, G; Levy, G; Marotta, P; Muehlbacher, F; Samuel, D; Sanjuan, F; Villamil, F; Wu, Y | 1 |
| Ballarín, JA; Cabezas, A; Calero, F; García Camín, RM | 1 |
| Smith, RM | 1 |
| Chiu, MY; Josephson, MA; Marshall, C; Schumm, LP; Sprague, SM; Thistlethwaite, JR | 1 |
| Acosta, D; Astorga, R; Escobar, MJ; Gentil, MA; López Hidalgo, R; Sánchez Ibáñez, R | 1 |
| Abbott, KC; Agodoa, LY; Bohen, EM; Koff, J; Lentine, KL; Oglesby, RJ; Schnitzler, MA | 1 |
| Benedetti, E; Dong, G; Jarzembowski, T; Panaro, F; Raofi, V; Sankary, H; Testa, G | 1 |
| Rostaing, L; Vincenti, F | 1 |
| Benedetti, E; Hatipoglu, B; Oberholzer, J; Sankary, HN; Testa, G; Thielke, J | 1 |
| Castagneto, M; Friman, S; Klinger, M; Martinek, A; Nonnast-Daniel, B; Russ, GR; Scheuermann, EH; Tuncer, M; Vincenti, F; Wiecek, A | 1 |
| Ergün, I; Keven, K | 1 |
| Bondor, CI; Kessler, M; Marin, M; Renoult, E | 1 |
| Abramowicz, D; Bouchta, NB; Broeders, N; Ghisdal, L; Hoang, AD; Surquin, M; Wissing, KM | 1 |
| Arroyo, LH; Baran, DA; Goldstein, DJ; Mele, L; Neacy, C; Prendergast, TW; Ribner, HS; Weinberg, AD; Zucker, MJ | 1 |
| Groggel, GC; Lane, JT; Puumala, SE; Stevens, RB; Sulanc, E; Wrenshall, LE | 1 |
| Araki, M; Derweesh, IH; Faiman, C; Flechner, LM; Flechner, SM; Goldfarb, D; Ismail, HR; Modlin, C; Novick, AC; Zhou, L | 1 |
| Baliellas, C; Castellote, J; Fabregat, J; Figueras, J; Garcia-Gil, A; Gonzalez-Pinto, I; Lladó, L; Memba, R; Rafecas, A; Ramos, E; Serrano, T; Torras, J; Xiol, X | 1 |
| Bernard, S; Boillot, O; Bouffard, Y; Dumortier, J | 1 |
| Castagneto, M; Citterio, F; Favi, E; Nanni, G; Romagnoli, J; Salerno, MP; Spagnoletti, G; Tondolo, V | 1 |
| Asberg, A; Fauchald, P; Hartmann, A; Holdaas, H; Jenssen, T; Johnsen, LF; Line, PD; Midtvedt, K; Narverud, J; Reisaeter, AV | 1 |
| Cantisani, G; Cillo, U; Clavien, PA; Friman, S; Grazi, GL; Jones, R; Klintmalm, G; Levy, G; McCormick, PA; Mühlbacher, F; Otto, G; Pollard, S; Samuel, D; Sanjuan, F; Villamil, F; Wu, Y | 1 |
| Akhlaghi, F; Gohh, RY; Harmon, M; Patel, CG | 1 |
| Budde, K; Campistol, JM; Chadban, S; Citterio, F; El-Shahawy, M; Friman, S; Goto, N; Jenssen, T; Marchetti, P; Pescovitz, MD; Rostaing, L; Scheuermann, E; Tuncer, M; Uchida, K; Vincenti, F; Wiecek, A | 1 |
| Al Najjar, A; Benhamou, PY; Cassuto, E; Cointault, O; Dantal, J; Delahousse, M; Di Giambattista, F; Kamar, N; Lefrançois, N; Mariat, C; Touchard, G; Villemain, F | 1 |
| Balamurugan, AN; Gunasekaran, S; Nelson, EJ; Ramakrishna, B | 1 |
| Brennan, DC; Burroughs, TE; Hardinger, K; Irish, WD; Lentine, KL; Machnicki, G; Schnitzler, MA; Swindle, J; Takemoto, SK | 1 |
| Campistol, JM; Gutiérrez-Dalmau, A; Oppenheimer, F; Ramos-Cebrián, M; Torregrosa, JV | 1 |
| Aloush, AA; Chakinala, MM; Hachem, RR; Lynch, JP; Meyers, BF; Patterson, GA; Trulock, EP; Yusen, RD | 1 |
| Abramowicz, D; Bouchta, NB; Broeders, N; Crenier, L; Ghisdal, L; Hoang, AD; Wissing, KM | 1 |
| Alvarez, A; Checa, M; Cobo, M; Delgado, P; Gallego, R; García, JJ; González-Posada, JM; Hernández, D; Hortal, L; Morales, A; Pérez, L; Porrini, E; Salido, E; Torres, A | 1 |
| Daloze, P; Demirbas, A; Ekberg, H; Frei, U; Grinyó, JM; Gürkan, A; Halloran, PF; Hugo, C; Margreiter, R; Nashan, B; Tedesco-Silva, H; Vanrenterghem, Y; Vítko, S | 1 |
| Al-Najjar, A; Barbet, C; Büchler, M; Chatelet, V; Doute, C; Gatault, P; Halimi, JM; Lebranchu, Y; Marlière, JF; Nivet, H; Roland, M | 1 |
| Chadban, S | 1 |
| Gill, JS; Johnston, O; Rose, CL; Webster, AC | 1 |
| Chugh, KS; Jha, V; Minz, M; Sakhuja, V; Sharma, UK | 1 |
| Boccagni, P; Emre, S; Jindal, RM; Miller, CM; Popescu, I; Schwartz, ME | 1 |
| Abouljoud, MS; Klintmalm, GB; Levy, MF | 1 |
| Rooth, P; Shi, CL; Täljedal, IB | 1 |
| Conway, PA; Davis, CP; Madras, PN; Monaco, AP; Sahyoun, AI; Shaffer, D; Simpson, MA | 1 |
| Cohan, J; Fabrega, AJ; Meslar, P; Pollak, R | 1 |
| Brinkmann, C; Jost, U; Oldhafer, K; Pichlmayr, R; Ringe, B; Winkler, M | 1 |
| Fryer, JP; Gillingham, K; Granger, DK; Leventhal, JR; Matas, AJ; Najarian, JS | 1 |
| Ahonen, J; Eklund, BH; Häyry, PJ; Höckerstedt, KV; Isoniemi, HM; Krogerus, L; Salmela, KE; Tikkanen, MJ; von Willebrand, EO | 1 |
| Broyer, M; Crosnier, H; Robert, JJ; Tete, MJ | 1 |
| Chidester, PD; Connito, DJ | 1 |
| D'Elia, JA; Gleason, RE; Monaco, AP; Shaffer, D; Weinrauch, LA | 1 |
| Armenti, VT; Curtis, JJ; First, MR; Monaco, AP; Schroeder, TJ; Simpson, MA | 1 |
| Hermann, E; Kanzler, S; Lohse, AW; Meyer zum Büschenfelde, KH; Otto, G; Schirmacher, P | 1 |
| Alexander, JW; First, MR; Hariharan, S; Schroeder, TJ | 1 |
| Filo, RS; Hughes, D; Jindal, RM; Leapman, SB; Lumeng, L; Milgrom, ML; Pescovitz, MD; Sidner, RA | 1 |
| Allen, RD; Bovington, KJ; Chapman, JR; O'Connell, PJ | 1 |
| Andreu, H; Bustamante, J; Cirera, I; Esmatjes, E; García-Valdecasas, JC; González, E; Grande, L; Marroni, C; Navasa, M; Rimola, A; Rodés, J | 1 |
| Bolaji, OO; Islam, SI; Masuda, QN; Shaheen, FM; Sheikh, IA | 1 |
| Alexander, JW; First, MR; Hariharan, S; Marterre, WF | 1 |
| Jacobs, U; Klehr, HU; Klein, B; Miersch, WD; Molitor, D | 1 |
| Deierhoi, MH; Filo, RS; Miller, J; Pirsch, JD; Vincenti, F | 1 |
| Lee, DB | 1 |
| Brandis, M; Máttyus, I; Miltényi, M; Schwarz, A; Tulassay, T; Zimmerhackl, LB | 1 |
| Gruessner, RW | 1 |
| Arbustini, E; Campana, C; Gavazzi, A; Goggi, C; Grossi, P; Ippoliti, G; Martinelli, L; Pellegrini, C; Regazzi, M; Rinaldi, M; Vigano, M | 1 |
| Adams, PL; Freedman, BI; Heise, ER; Thacker, LR | 1 |
| Anjum, MR; Bowley, JN; Drafts, HH; Humphries, AL; Mulloy, LL; Wynn, JJ | 1 |
| Alfrey, EJ; Dafoe, DC; Krieger, NR; Lee, CM; Scandling, JD | 1 |
| Canzanello, VJ; Krom, RA; Porayko, MK; Schwartz, L; Taler, SJ; Textor, SC; Wiesner, RH | 1 |
| Egeland, T; Fauchald, P; Hartmann, A; Hjelmesaeth, J; Kofstad, J; Leivestad, T; Stenstrøm, J | 1 |
| Bilir, B; Everson, G; Kam, I; Karrer, F; Shrestha, R; Stegall, MD; Steinberg, T; Wachs, ME | 1 |
| Cavaillé-Coll, MW; Elashoff, MR | 1 |
| Neylan, JF | 1 |
| Bruce, DS; Cronin, DC; Josephson, MA; Loss, GE; Millis, JM; Newell, KA; Pellar, S; Thistlethwaite, JR; Woodle, ES | 1 |
| Abdulkarim, AB; Elmer, DS; Fraga, D; Gaber, AO; Hathaway, DK; Reddy, K; Shokouh-Amiri, H; Stratta, RJ | 1 |
| Bouillon, R; Casteels, K; Depovere, J; Laureys, J; Mathieu, C; Valckx, D; Waer, M | 1 |
| Chapman, W; Geevarghese, S; Helderman, JH; MacDonell, R; Payne, J; Pinson, CW; Richie, R; Van Buren, D; Wright, JK | 2 |
| Asberg, A; Berg, KJ; Bergan, S; Hartmann, A; Sagedal, S | 1 |
| Aroldi, A; Elli, A; Montagnino, G; Ponticelli, C; Tarantino, A; Vegeto, A | 1 |
| Brandão, AB; Cantisani, GP; Cassal, AP; Diehl, JL; Hoppe, L; Leipnitz, I; Marroni, CA; Schlindwein, E; Zanotelli, ML | 1 |
| Alejandro, R; Angelico, MC; Battezzati, A; Fernandez, LA; Lehmann, R; Luzi, L; Ricordi, C; Tzakis, A | 1 |
| Alam, R; Khanum, A; Rahman, H; Rashid, HU | 1 |
| Vanrenterghem, YF | 1 |
| Hauss, J; Kohlhaw, K; Lamesch, P; List, C; Lohmann, T; Richter, O; Schwarz, C; Seissler, J; Wenzke, M | 1 |
| Ahn, C; Bang, BK; Kang, CM; Kim, SI; Kim, SJ; Kim, YS; Koh, YB; Kwak, JY; Kwon, OJ; Moon, IS; Moon, JI; Park, K | 1 |
| Jawad, F; Rizvi, SA | 1 |
| Guimarães, S; Henriques, A; Queirós, J; Sarmento, A; Silva, F; Vargas, G | 1 |
| Butani, L; Makker, SP | 1 |
| Cosio, FG; Ferguson, RM; Henry, ML; Osei, K; Pesavento, TE | 1 |
| Borka, P; Járay, J; Lázár, N; Perner, F; Remport, A; Sasvári, I; Toronyi, E | 1 |
| Ahsan, N; Corwin, C; Danovitch, G; Fitzsimmons, WE; Gonwa, T; Halloran, P; Hardy, M; Johnson, C; Light, J; Metzger, R; Mulloy, L; Rocher, L; Salm, K; Scandling, J; Shield , C; Sorensen, J; Stegall, M; Tolzman, D; VanVeldhuisen, P; Wachs, M | 1 |
| Jawad, F; Naqvi, A; Rizvi, A | 1 |
| Weir, M | 1 |
| First, MR | 1 |
| Boots, JMM; Christiaans, MHL; Nieman, FHM; van Duijnhoven, EM; van Hooff, JP; Wolffenbuttel, BHR | 1 |
| Al-Mousawi, M; Costandi, JN; Gupta, RK; Johny, KV; Muzairai, I; Nampoory, MR; Ninan, VT; Samhan, M | 1 |
| Chen, C; Hu, Q; Yao, X | 1 |
| Adiku, W; Aman, H; Baraqdar, A; Basri, N; Bonatero, I; Nezamuddin, N | 1 |
| Murthy, BV; Prakash, BS; Prasad, TN; Subramanyam, K | 1 |
| Koselj, KM; Koselj, M; Kveder, R | 1 |
| Arakawa, K; Mitsuo, M; Nakai, I; Nakaji, K; Oka, T; Omori, Y; Yasumura, T | 1 |
| Fung, J; Hakala, T; Jensen, C; Jordan, M; McCauley, J; Scantlebury, V; Shapiro, R; Simmons, R; Starzl, TE; Tzakis, A | 1 |
| Akazawa, S; Matsuya, F; Nagataki, S; Nakanishi, T; Saito, Y; Tahara, D; Yamaguchi, Y; Yamamoto, H; Yamasaki, H; Yokota, A | 1 |
| Daskalakis, P; Davis, R; Delaney, V; Friedman, EA; Hong, JH; Sommer, BG; Sumrani, NB | 1 |
28 review(s) available for cyclosporine and Diabetes Mellitus
| Article | Year |
|---|---|
Systematic review and meta-analysis of calcineurin inhibitors on long-term prognosis of renal transplant patients.
Topics: Calcineurin Inhibitors; Cyclosporine; Diabetes Mellitus; Graft Rejection; Humans; Kidney Transplantation; Prognosis; Tacrolimus | 2022 |
Diabetes and Cardiovascular Risk in Renal Transplant Patients.
Topics: Animals; Cardiovascular Diseases; Cyclosporine; Diabetes Mellitus; Heart Disease Risk Factors; Humans; Immunosuppressive Agents; Insulin Resistance; Kidney Failure, Chronic; Kidney Transplantation; Postoperative Complications; Prevalence; Renal Dialysis; Tacrolimus; TOR Serine-Threonine Kinases; Transplant Recipients | 2021 |
Treatment of toxic epidermal necrolysis by a multidisciplinary team. A review of literature and treatment results.
Topics: Adrenal Cortex Hormones; Allopurinol; Anti-Bacterial Agents; Anticonvulsants; Bandages; British Columbia; Comorbidity; Cyclosporine; Dermatologic Agents; Dermatology; Diabetes Mellitus; Dietetics; Disease Management; Female; Gout; Gout Suppressants; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Immunologic Factors; Intensive Care Units; Length of Stay; Male; Middle Aged; Mouth Mucosa; Neoplasms; Patient Care Team; Retrospective Studies; Seizures; Stevens-Johnson Syndrome; Surgery, Plastic; Torso | 2018 |
Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy: an analysis of two randomized, multicenter trials.
Topics: Aged; Cyclosporine; Diabetes Mellitus; Disease Progression; Everolimus; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Multicenter Studies as Topic; Randomized Controlled Trials as Topic | 2018 |
Recurrent hepatitis C virus infection post liver transplantation: impact of choice of calcineurin inhibitor.
Topics: Calcineurin Inhibitors; Cyclosporine; Diabetes Mellitus; Fibrosis; Graft Rejection; Hepatitis C; Humans; Immunosuppressive Agents; Insulin Resistance; Liver Transplantation; Recurrence; Virus Replication | 2013 |
Current treatment strategies for age-related ocular conditions.
Topics: Aged; Antibodies, Monoclonal, Humanized; Bevacizumab; Clinical Trials as Topic; Cyclosporine; Diabetes Mellitus; Diabetic Retinopathy; Disease Progression; Dry Eye Syndromes; Glaucoma; Glycated Hemoglobin; Humans; Macular Degeneration; Medication Adherence; Ophthalmic Solutions; Ophthalmologic Surgical Procedures; Ranibizumab; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Vascular Endothelial Growth Factor A | 2013 |
Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients.
Topics: Adult; Bronchiolitis Obliterans; Cyclosporine; Diabetes Mellitus; Graft Rejection; Humans; Hypertension; Immune Tolerance; Immunosuppression Therapy; Immunosuppressive Agents; Lung Transplantation; Middle Aged; Randomized Controlled Trials as Topic; Tacrolimus | 2013 |
Psoriasis is a systemic disease with multiple cardiovascular and metabolic comorbidities.
Topics: Acitretin; Adipokines; Alcoholism; Antibodies, Monoclonal, Humanized; Cardiovascular Diseases; Comorbidity; Cyclosporine; Dermatologic Agents; Diabetes Mellitus; Fumarates; Humans; Immunosuppressive Agents; Inflammation; Metabolic Syndrome; Methotrexate; Obesity; Psoriasis; Risk Factors; Smoking; Tumor Necrosis Factor-alpha; Ustekinumab | 2015 |
Immunosuppression and Post-transplant Hyperglycemia.
Topics: Adrenal Cortex Hormones; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Diabetes Mellitus; Everolimus; Graft Rejection; Humans; Hyperglycemia; Immunosuppressive Agents; Mycophenolic Acid; Postoperative Complications; Sirolimus; Tacrolimus; TOR Serine-Threonine Kinases; Transplantation | 2015 |
New-onset diabetes mellitus after pediatric liver transplantation.
Topics: Albuminuria; Child; Cyclosporine; Diabetes Mellitus; Diabetic Retinopathy; Glucocorticoids; Humans; Hyperlipidemias; Hypertension; Immunosuppressive Agents; Insulin; Liver Failure; Liver Transplantation; Metformin; Pediatrics; Risk Factors; Sirolimus; Tacrolimus | 2015 |
Calcineurin Inhibitors: Pharmacologic Mechanisms Impacting Both Insulin Resistance and Insulin Secretion Leading to Glucose Dysregulation and Diabetes Mellitus.
Topics: Calcineurin; Calcineurin Inhibitors; Cyclosporine; Diabetes Mellitus; Glucose; Humans; Immunosuppressive Agents; Insulin; Insulin Resistance; Insulin Secretion; Tacrolimus | 2017 |
Diagnostic accuracy of glycated hemoglobin for post-transplantation diabetes mellitus after kidney transplantation: systematic review and meta-analysis.
Topics: Adrenal Cortex Hormones; Cyclosporine; Diabetes Mellitus; Glucose Tolerance Test; Glycated Hemoglobin; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Postoperative Complications; Sensitivity and Specificity; Tacrolimus | 2017 |
Very early steroid withdrawal or complete avoidance for kidney transplant recipients: a systematic review.
Topics: Adrenal Cortex Hormones; Cyclosporine; Diabetes Mellitus; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Mycophenolic Acid; Postoperative Care; Prognosis; Randomized Controlled Trials as Topic; Survival Analysis; Tacrolimus; Time Factors; Transplantation Immunology; Withholding Treatment | 2012 |
Optimization of the use of Calcineurin inhibitors in liver transplantation.
Topics: Calcineurin Inhibitors; Cyclosporine; Diabetes Mellitus; Drug Administration Schedule; Drug Substitution; Graft Rejection; Hepatitis C; Humans; Hypertension; Immunosuppressive Agents; Kidney Failure, Chronic; Liver Transplantation; Tacrolimus; TOR Serine-Threonine Kinases | 2012 |
Tacrolimus in transplant rejection.
Topics: Cyclosporine; Diabetes Mellitus; Drug Therapy, Combination; Graft Rejection; Humans; Immunosuppressive Agents; Mycophenolic Acid; Organ Transplantation; Postoperative Complications; Randomized Controlled Trials as Topic; Tacrolimus; Treatment Outcome | 2013 |
[Metabolic modifications related to immunosuppressive drugs].
Topics: Anticholesteremic Agents; Cyclosporine; Diabetes Mellitus; Heart Transplantation; Humans; Hyperlipidemias; Immunosuppressive Agents; Insulin Resistance; Liver Transplantation; Lung Transplantation; Mycophenolic Acid; Prednisone; Prognosis; Sirolimus; Tacrolimus; Transplantation Immunology | 2002 |
Cardiovascular toxicities of immunosuppressive agents.
Topics: Adrenal Cortex Hormones; Animals; Cardiovascular System; Coronary Artery Disease; Cyclosporine; Diabetes Mellitus; Humans; Hyperlipidemias; Hypertension; Immunosuppressive Agents; Sirolimus; Tacrolimus | 2002 |
Metabolic aspects of tacrolimus in renal transplantation. Consequences for the choice of an immunosuppressive regimen and for the management of post-transplant diabetes mellitus.
Topics: Adrenal Cortex Hormones; Clinical Protocols; Cyclosporine; Diabetes Mellitus; Glucose; Humans; Immunosuppressive Agents; Kidney Transplantation; Metabolic Diseases; Risk Factors; Tacrolimus | 2003 |
Post-liver transplant obesity and diabetes.
Topics: Cyclosporine; Diabetes Mellitus; Humans; Immunosuppressive Agents; Liver Transplantation; Obesity; Risk Factors | 2003 |
Steroid immunosuppression in kidney transplantation: a passing era.
Topics: Adrenal Cortex Hormones; Azathioprine; Blood Pressure; Cyclosporine; Diabetes Mellitus; Graft Rejection; Humans; Hypertension; Immunosuppressive Agents; Kidney; Kidney Transplantation; Lipid Metabolism; Sirolimus; Substance Withdrawal Syndrome; Transplantation Immunology | 2004 |
New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis.
Topics: Calcineurin Inhibitors; Cyclosporine; Diabetes Mellitus; Diabetes Mellitus, Type 1; Humans; Immunosuppressive Agents; Organ Transplantation; Prospective Studies; Retrospective Studies; Tacrolimus; Time Factors | 2004 |
CMV prophylaxis: a useful step towards prevention of post-transplant diabetes?
Topics: Cyclosporine; Cytomegalovirus Infections; Diabetes Mellitus; Humans; Immunosuppressive Agents; Kidney Transplantation; Postoperative Complications; Tacrolimus | 2004 |
Conversion from tacrolimus to cyclosporine A for new-onset diabetes after transplantation: a single-centre experience in renal transplanted patients and review of the literature.
Topics: Blood Glucose; Cyclosporine; Diabetes Mellitus; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Tacrolimus | 2008 |
New-onset diabetes after transplantation--should it be a factor in choosing an immunosuppressant regimen for kidney transplant recipients.
Topics: Age of Onset; Cyclosporine; Diabetes Mellitus; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Risk Assessment; Tacrolimus; Transplantation Immunology | 2008 |
[Sugar diabetes after renal transplantation in children].
Topics: Adolescent; Adrenal Cortex Hormones; Child; Child, Preschool; Cyclosporine; Diabetes Mellitus; Female; Follow-Up Studies; Glucose Tolerance Test; Hospitals, Pediatric; Humans; Kidney Function Tests; Kidney Transplantation; Male; Paris; Postoperative Complications; Risk Factors | 1993 |
Renal excretion of endothelin in children.
Topics: Adolescent; Adult; Age Factors; Child; Child, Preschool; Cyclosporine; Diabetes Mellitus; Endothelins; Humans; Infant, Newborn; Kidney; Receptors, Endothelin; Reference Values | 1997 |
Which calcineurin inhibitor is preferred in renal transplantation: tacrolimus or cyclosporine?
Topics: Arteriosclerosis; Calcineurin Inhibitors; Cyclosporine; Diabetes Mellitus; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Tacrolimus; Time Factors | 1999 |
Impact of immunosuppressive regimes on posttransplant diabetes mellitus.
Topics: Adrenal Cortex Hormones; Cyclosporine; Diabetes Mellitus; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Organ Transplantation; Tacrolimus | 2001 |
50 trial(s) available for cyclosporine and Diabetes Mellitus
| Article | Year |
|---|---|
Prospective randomized study of conversion from tacrolimus to cyclosporine A to improve glucose metabolism in patients with posttransplant diabetes mellitus after renal transplantation.
Topics: Cyclosporine; Diabetes Mellitus; Female; Follow-Up Studies; Glomerular Filtration Rate; Glucose; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Function Tests; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Prognosis; Prospective Studies; Risk Factors; Tacrolimus | 2018 |
Long-term follow-up of a phase III clinical trial comparing tacrolimus extended-release/MMF, tacrolimus/MMF, and cyclosporine/MMF in de novo kidney transplant recipients.
Topics: Adult; Cyclosporine; Delayed-Action Preparations; Diabetes Mellitus; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Humans; Illinois; Immunosuppressive Agents; Kaplan-Meier Estimate; Kidney; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Risk Factors; Tacrolimus; Time Factors; Treatment Outcome | 2014 |
Side effects of the calcineurin inhibitor, such as new-onset diabetes after kidney transplantation.
Topics: Adult; Age Factors; Aged; Atrophy; Biopsy; Blood Glucose; Calcineurin; Calcineurin Inhibitors; Cyclosporine; Diabetes Mellitus; Fasting; Female; Fibrosis; Glucose Tolerance Test; Graft Rejection; Humans; Hungary; Immunosuppressive Agents; Incidence; Kidney; Kidney Transplantation; Male; Middle Aged; Risk Factors; Tacrolimus; Time Factors | 2014 |
Conversion from tacrolimus to cyclosporine in patients with new-onset diabetes after renal transplant: an open-label randomized prospective pilot study.
Topics: Adult; Cyclosporine; Diabetes Mellitus; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; India; Kidney Failure, Chronic; Kidney Transplantation; Male; Pilot Projects; Prospective Studies; Tacrolimus | 2015 |
Comparative risk of impaired glucose metabolism associated with cyclosporine versus tacrolimus in the late posttransplant period.
Topics: Blood Glucose; Cohort Studies; Cyclosporine; Diabetes Mellitus; Fasting; Female; Follow-Up Studies; Glucose; Graft Survival; Guidelines as Topic; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Middle Aged; Risk Factors; Tacrolimus; Time Factors; Treatment Outcome; United States | 2008 |
Randomized trial of cyclosporine and tacrolimus therapy with steroid withdrawal in living-donor renal transplantation: 5-year follow-up.
Topics: Adult; Cyclosporine; Diabetes Mellitus; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Kidney Transplantation; Living Donors; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; Steroids; Tacrolimus | 2010 |
Belatacept-based regimens are associated with improved cardiovascular and metabolic risk factors compared with cyclosporine in kidney transplant recipients (BENEFIT and BENEFIT-EXT studies).
Topics: Abatacept; Adult; Aged; Blood Glucose; Blood Pressure; Cardiovascular Diseases; Cyclosporine; Diabetes Mellitus; Female; Humans; Immunoconjugates; Immunosuppressive Agents; Kidney Transplantation; Lipids; Male; Middle Aged; Risk Factors | 2011 |
Regression of new-onset diabetes mellitus after conversion from tacrolimus to cyclosporine in liver transplant patients: results of a pilot study.
Topics: Adrenal Cortex Hormones; Alkaline Phosphatase; Bilirubin; Cholesterol; Creatinine; Cyclosporine; Diabetes Mellitus; Female; gamma-Glutamyltransferase; Graft Rejection; Humans; Hypertension; Hypoglycemic Agents; Immunosuppressive Agents; Insulin; Liver Transplantation; Logistic Models; Male; Middle Aged; Pilot Projects; Prospective Studies; Tacrolimus | 2011 |
Randomized trial of immunosuppressive regimens in renal transplantation.
Topics: Adolescent; Adult; Aged; Cyclosporine; Diabetes Mellitus; Drug Therapy, Combination; Dyslipidemias; Female; Florida; Graft Rejection; Guideline Adherence; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Infections; Kidney Function Tests; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Sirolimus; Young Adult | 2011 |
Calcineurin inhibitors acutely improve insulin sensitivity without affecting insulin secretion in healthy human volunteers.
Topics: Adult; Analysis of Variance; Calcineurin; Calcineurin Inhibitors; Cross-Over Studies; Cyclosporine; Diabetes Mellitus; Double-Blind Method; Glucose; Glucose Clamp Technique; Glucose Tolerance Test; Humans; Immunosuppressive Agents; Infusions, Intravenous; Insulin; Insulin Resistance; Insulin Secretion; Male; Middle Aged; Tacrolimus; Young Adult | 2012 |
Comparison of tacrolimus and neoral-based immunosuppressive regimens in renal transplantation patients: singles-center experience.
Topics: Adult; Cyclosporine; Cytomegalovirus Infections; Diabetes Mellitus; Drug Therapy, Combination; Female; Graft Rejection; Histocompatibility Testing; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Postoperative Complications; Tacrolimus; Treatment Failure | 2002 |
Cardiovascular risk factors of sirolimus compared with cyclosporine: early experience from two randomized trials in renal transplantation.
Topics: Cardiovascular Diseases; Cholesterol; Cyclosporine; Diabetes Mellitus; Follow-Up Studies; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Risk Factors; Sirolimus; Time Factors; Triglycerides | 2003 |
Determinants of insulin secretion after renal transplantation.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Area Under Curve; Cyclosporine; Cytomegalovirus Infections; Diabetes Mellitus; Diuretics; Female; Furosemide; Glucose Tolerance Test; HLA-B27 Antigen; Humans; Immunosuppressive Agents; Insulin; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Regression Analysis; Risk Factors | 2003 |
Conversion from calcineurin inhibitors to mycophenolate mofetil in liver transplant recipients with diabetes mellitus.
Topics: Blood Glucose; C-Peptide; Cyclosporine; Diabetes Mellitus; Glycated Hemoglobin; Graft Rejection; Humans; Immunosuppressive Agents; Liver Transplantation; Mycophenolic Acid; Tacrolimus | 2003 |
A randomized long-term trial of tacrolimus/sirolimus versus tacrolimus/mycophenolate mofetil versus cyclosporine (NEORAL)/sirolimus in renal transplantation. II. Survival, function, and protocol compliance at 1 year.
Topics: Creatinine; Cyclosporine; Diabetes Mellitus; Drug Therapy, Combination; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Kidney Function Tests; Kidney Transplantation; Lymphocele; Mycophenolic Acid; Patient Compliance; Postoperative Complications; Sirolimus; Surgical Wound Infection; Tacrolimus; Time Factors | 2004 |
Results of lis2t, a multicenter, randomized study comparing cyclosporine microemulsion with C2 monitoring and tacrolimus with C0 monitoring in de novo liver transplantation.
Topics: Adult; Aged; Biopsy; Cyclosporine; Diabetes Mellitus; Emulsions; Graft Rejection; Hepacivirus; Humans; Immunosuppressive Agents; Incidence; Liver; Liver Diseases; Liver Transplantation; Middle Aged; Monitoring, Physiologic; Tacrolimus; Time Factors; Treatment Outcome | 2004 |
Calcium and calcitriol prophylaxis attenuates posttransplant bone loss.
Topics: Absorptiometry, Photon; Bone Density; Bone Diseases, Metabolic; Calcitriol; Calcium; Calcium Channel Agonists; Cyclosporine; Diabetes Mellitus; Drug Therapy, Combination; Femur Neck; Humans; Immunosuppressive Agents; Kidney Transplantation; Lumbar Vertebrae; Pancreas Transplantation; Radius; Tacrolimus; Vitamin D | 2004 |
Long-term results of a prospective randomized trial comparing tacrolimus versus cyclosporine in African-American recipients of primary cadaver renal transplant.
Topics: Acute Disease; Adult; Black or African American; Cholesterol; Creatinine; Cyclosporine; Diabetes Mellitus; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Longitudinal Studies; Male; Middle Aged; Postoperative Complications; Tacrolimus | 2005 |
Immediate conversion from tacrolimus to cyclosporine in the treatment of posttransplantation diabetes mellitus.
Topics: Adult; Cyclosporine; Diabetes Mellitus; Humans; Immunosuppressive Agents; Kidney Transplantation; Postoperative Complications; Retrospective Studies; Tacrolimus | 2005 |
Prospective, multicenter, randomized trial to compare incidence of new-onset diabetes mellitus and glucose metabolism in patients receiving cyclosporine microemulsion versus tacrolimus after de novo kidney transplantation.
Topics: Adrenal Cortex Hormones; Adult; Body Weight; Cyclosporine; Diabetes Mellitus; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Reoperation; Tacrolimus; Tissue Donors; Treatment Failure; United States; White People | 2005 |
De novo immunosuppression with sirolimus and tacrolimus in heart transplant recipients compared with cyclosporine and mycophenolate mofetil: a one-year follow-up analysis.
Topics: Adrenal Cortex Hormones; Cyclosporine; Diabetes Mellitus; Follow-Up Studies; Glucocorticoids; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Mycophenolic Acid; Postoperative Complications; Sirolimus; Survival Analysis; Tacrolimus; Time Factors | 2005 |
Immunosuppression without steroids in liver transplantation is safe and reduces infection and metabolic complications: results from a prospective multicenter randomized study.
Topics: Adult; Aged; Antibodies, Monoclonal; Basiliximab; Cyclosporine; Diabetes Mellitus; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Hepacivirus; Hepatitis C; Humans; Hypertension; Immunosuppression Therapy; Immunosuppressive Agents; Liver; Liver Transplantation; Male; Middle Aged; Prednisone; Prospective Studies; Recombinant Fusion Proteins; Recurrence; Steroids; Survival Rate; Treatment Outcome | 2006 |
Calcineurin inhibitor avoidance with daclizumab, mycophenolate mofetil, and prednisolone in DR-matched de novo kidney transplant recipients.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Calcineurin Inhibitors; Cyclosporine; Daclizumab; Diabetes Mellitus; Female; Glomerular Filtration Rate; Graft Rejection; Graft Survival; Histocompatibility; Humans; Hypertension; Immunoglobulin G; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Lipids; Male; Middle Aged; Mycophenolic Acid; Prednisolone; Tacrolimus; Tissue Donors; Urinary Tract Infections | 2006 |
12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
Topics: Age Distribution; Creatinine; Cyclosporine; Diabetes Mellitus; Emulsions; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Hepacivirus; Humans; Hypoglycemic Agents; Immunosuppressive Agents; Liver Transplantation; Living Donors; Longitudinal Studies; Male; Monitoring, Physiologic; Steroids; Survival Analysis; Tacrolimus; Time Factors; Treatment Outcome | 2006 |
Concentrations of mycophenolic acid and glucuronide metabolites under concomitant therapy with cyclosporine or tacrolimus.
Topics: Administration, Oral; Aged; Animals; Antibiotics, Antineoplastic; Area Under Curve; Cyclosporine; Diabetes Mellitus; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Glucuronides; Humans; Immunosuppressive Agents; Ketoconazole; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Prednisone; Rats; Rats, Sprague-Dawley; Tacrolimus | 2007 |
Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus.
Topics: Adolescent; Adult; Aged; Cyclosporine; Diabetes Mellitus; Drug Therapy, Combination; Glucose; Humans; Immunosuppressive Agents; Kidney Transplantation; Metabolic Diseases; Middle Aged; Tacrolimus; Treatment Outcome | 2007 |
Conversion from tacrolimus to cyclosporine could improve control of posttransplant diabetes mellitus after renal transplantation.
Topics: Adolescent; Adult; Blood Glucose; Cyclosporine; Diabetes Mellitus; Drug Administration Schedule; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Prospective Studies; Tacrolimus | 2007 |
A randomized controlled trial of tacrolimus versus cyclosporine after lung transplantation.
Topics: Adult; Azathioprine; Bronchiolitis Obliterans; Bronchitis; Cyclosporine; Diabetes Mellitus; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Middle Aged; Postoperative Care; Tacrolimus | 2007 |
Reduced exposure to calcineurin inhibitors in renal transplantation.
Topics: Adrenal Cortex Hormones; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Calcineurin Inhibitors; Cyclosporine; Daclizumab; Diabetes Mellitus; Drug Therapy, Combination; Enzyme Inhibitors; Female; Glomerular Filtration Rate; Graft Rejection; Humans; Immunoglobulin G; Immunosuppressive Agents; Kaplan-Meier Estimate; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Opportunistic Infections; Prednisone; Sirolimus; Tacrolimus; Treatment Failure | 2007 |
Diabetogenicity of FK506 versus cyclosporine in liver transplant recipients.
Topics: Adult; Arteriosclerosis; Cyclosporine; Diabetes Mellitus; Dose-Response Relationship, Drug; Female; Glucose Tolerance Test; Graft Rejection; Humans; Liver Transplantation; Male; Middle Aged; Risk Factors; Tacrolimus | 1994 |
Hyperlipidemia after liver transplantation: long-term results of the FK506/cyclosporine A US Multicenter Trial. US Multicenter Study Group.
Topics: Adult; Alanine Transaminase; Alkaline Phosphatase; Analysis of Variance; Aspartate Aminotransferases; Creatinine; Cyclosporine; Diabetes Mellitus; Female; Follow-Up Studies; Glomerular Filtration Rate; Graft Rejection; Humans; Hyperlipidemias; Kidney Function Tests; Lipoproteins; Liver Function Tests; Liver Transplantation; Male; Tacrolimus; Time Factors; United States | 1995 |
Long-term consequences of different immunosuppressive regimens for renal allografts.
Topics: Adult; Azathioprine; Cyclosporine; Diabetes Mellitus; Drug Therapy, Combination; Female; Glomerular Mesangium; Glucose; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney; Kidney Transplantation; Lipids; Male; Methylprednisolone; Middle Aged; Nephritis, Interstitial; Time Factors | 1993 |
Role of calcium channel blockers in diabetic renal transplant patients: preliminary observations on protection from sepsis.
Topics: Adrenergic beta-Antagonists; Adult; Calcium Channel Blockers; Cyclosporine; Diabetes Complications; Diabetes Mellitus; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Sepsis; Survival Rate; Transplantation, Homologous | 1995 |
Reversal of cyclosporine malabsorption in diabetic recipients of simultaneous pancreas and kidney transplant using a microemulsion formulation.
Topics: Absorption; Adult; Capsules; Chemistry, Pharmaceutical; Cyclosporine; Diabetes Mellitus; Dose-Response Relationship, Drug; Humans; Immunosuppressive Agents; Kidney; Kidney Transplantation; Middle Aged; Pancreas Transplantation | 1996 |
A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group.
Topics: Acute Disease; Adult; Antilymphocyte Serum; Cadaver; Cause of Death; Clinical Protocols; Creatinine; Cross-Over Studies; Cyclosporine; Diabetes Mellitus; Female; Graft Rejection; Humans; Immunosuppressive Agents; Insulin; Kidney Transplantation; Male; Patient Selection; Regression Analysis; Tacrolimus | 1997 |
Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Bone Marrow Transplantation; Case-Control Studies; Cyclosporine; Diabetes Mellitus; Diabetes Mellitus, Type 1; Female; Follow-Up Studies; Gastrointestinal Diseases; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Incidence; Kidney Diseases; Kidney Transplantation; Lymphoma; Male; Muromonab-CD3; Mycophenolic Acid; Nervous System Diseases; Pancreas Transplantation; Prednisone; Prospective Studies; Randomized Controlled Trials as Topic; Survival Rate; Tacrolimus; Transplantation, Homologous | 1997 |
FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study.
Topics: Acute Disease; Bacterial Infections; Cardiac Catheterization; Coronary Disease; Cyclosporine; Diabetes Mellitus; Female; Follow-Up Studies; Graft Rejection; Heart Transplantation; Humans; Hypertension; Immunosuppressive Agents; Incidence; Kidney; Liver; Lymphocyte Subsets; Male; Middle Aged; Nervous System; Prevalence; Prospective Studies; Survival Rate; Tacrolimus; Treatment Outcome | 1997 |
Outcomes in diabetic patients after simultaneous pancreas-kidney versus kidney alone transplantation.
Topics: Adolescent; Adult; Azathioprine; Cyclosporine; Diabetes Mellitus; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Pancreas Transplantation; Retrospective Studies; Tacrolimus; Treatment Outcome | 1997 |
Prednisone withdrawal 14 days after liver transplantation with mycophenolate: a prospective trial of cyclosporine and tacrolimus.
Topics: Acute Disease; Adult; Cyclosporine; Diabetes Mellitus; Drug Administration Schedule; Graft Rejection; Graft Survival; Humans; Hypertension; Immunosuppression Therapy; Immunosuppressive Agents; Liver; Liver Transplantation; Mycophenolic Acid; Prednisone; Prospective Studies; Survival Analysis; Tacrolimus; Time Factors | 1997 |
Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine. FK506 Kidney Transplant Study Group.
Topics: Adult; Black or African American; Black People; Cyclosporine; Diabetes Mellitus; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Postoperative Complications; Survival Rate; Tacrolimus; Time Factors; United States; White People | 1998 |
Renal function in primary liver transplant recipients receiving neoral (cyclosporine) versus prograf (tacrolimus).
Topics: Analysis of Variance; Azathioprine; Creatinine; Cyclosporine; Diabetes Mellitus; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kidney; Liver Transplantation; Postoperative Complications; Prednisone; Prospective Studies; Regression Analysis; Survival Rate; Tacrolimus; Time Factors | 1998 |
Impact of Sandimmune, Neoral, and Prograf on rejection incidence and renal function in primary liver transplant recipients.
Topics: Adult; Analysis of Variance; Azathioprine; Communicable Diseases; Creatinine; Cyclosporine; Diabetes Mellitus; Drug Therapy, Combination; Graft Rejection; Humans; Hypertension; Immunosuppressive Agents; Incidence; Kidney Function Tests; Liver Transplantation; Methylprednisolone Hemisuccinate; Postoperative Complications; Regression Analysis; Retrospective Studies; Tacrolimus | 1998 |
The effects of maintenance doses of FK506 versus cyclosporin A on glucose and lipid metabolism after orthotopic liver transplantation.
Topics: Blood Glucose; Cholesterol, HDL; Cyclosporine; Diabetes Mellitus; Energy Metabolism; Female; Glucose; Humans; Immunosuppressive Agents; Insulin; Lipids; Liver Transplantation; Male; Middle Aged; Tacrolimus | 1999 |
Diabetes mellitus and islet cell specific autoimmunity as adverse effects of immunsuppressive therapy by FK506/tacrolimus.
Topics: Adult; Autoimmunity; Blood Glucose; C-Peptide; Cyclosporine; Diabetes Mellitus; Female; Glucose Tolerance Test; Humans; Immunosuppressive Agents; Islets of Langerhans; Lipids; Liver Transplantation; Male; Middle Aged; Tacrolimus | 2000 |
Efficacy of tacrolimus in primary kidney transplant patients: multicenter, open-label prospective study.
Topics: ABO Blood-Group System; Adult; Creatinine; Cyclosporine; Diabetes Mellitus; Female; Graft Rejection; Histocompatibility Testing; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Prevalence; Tacrolimus; Time Factors | 2000 |
Posttransplant diabetes mellitus in live-related renal transplantation.
Topics: Adult; Cyclosporine; Diabetes Mellitus; Dose-Response Relationship, Drug; Drug Therapy, Combination; Family; Female; Glucose Tolerance Test; Humans; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Male; Methylprednisolone; Postoperative Complications; Prevalence | 2000 |
Mycofenolate mofetil-cyclosporine immunosuppression of kidney transplantation recipients with two different corticosteroid doses.
Topics: Adrenal Cortex Hormones; Cyclosporine; Diabetes Mellitus; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Infections; Kidney Transplantation; Leukopenia; Male; Mycophenolic Acid; Opportunistic Infections; Postoperative Complications; Prednisolone; Survival Rate | 2001 |
Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation: results at 2 years.
Topics: Administration, Oral; Adolescent; Adult; Antilymphocyte Serum; Azathioprine; Black People; Cadaver; Child; Cross-Over Studies; Cyclosporine; Diabetes Mellitus; Drug Monitoring; Drug Therapy, Combination; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Insulin; Kidney Function Tests; Kidney Transplantation; Kidney Tubular Necrosis, Acute; Mycophenolic Acid; Postoperative Complications; Survival Rate; Tacrolimus; Time Factors; Tissue Donors; United States; White People | 2001 |
Glucose metabolism in the first 3 years after renal transplantation in patients receiving tacrolimus versus cyclosporine-based immunosuppression.
Topics: Adult; Aged; Cyclosporine; Diabetes Mellitus; Female; Glucose; Humans; Hyperglycemia; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Postoperative Period; Tacrolimus; Time Factors | 2002 |
New onset of diabetes in FK 506 vs cyclosporine-treated kidney transplant recipients.
Topics: Adolescent; Adult; Child; Cyclosporine; Diabetes Mellitus; Graft Rejection; Humans; Kidney Transplantation; Methylprednisolone; Tacrolimus | 1991 |
125 other study(ies) available for cyclosporine and Diabetes Mellitus
| Article | Year |
|---|---|
Risk Factors for New-Onset Diabetes Mellitus After Heart Transplantation: A Nomogram Approach.
Topics: Cyclosporine; Diabetes Mellitus; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney Transplantation; Nomograms; Reproducibility of Results; Risk Factors; Sirolimus; Tacrolimus | 2022 |
Intravenous injection of cyclosporin A loaded lipid nanocapsules fights inflammation and immune system activation in a mouse model of diabetic retinopathy.
Topics: Animals; Cyclosporine; Cytokines; Diabetes Mellitus; Diabetic Retinopathy; Disease Models, Animal; Humans; Immune System; Inflammation; Injections, Intravenous; Lipids; Nanocapsules | 2023 |
Insulin Resistance in Nonobese Renal Allograft Recipients on Maintenance Doses of Cyclosporine or Tacrolimus.
Topics: Adult; Cyclosporine; Diabetes Mellitus; Female; Humans; Immunosuppressive Agents; Insulin Resistance; Kidney Transplantation; Male; Middle Aged; Tacrolimus; Transplant Recipients; Transplantation, Homologous | 2019 |
Effects of Different Immunosuppressive Drugs on Incretins in Renal Transplant Patients.
Topics: Adult; Blood Glucose; Case-Control Studies; Cyclosporine; Diabetes Mellitus; Gastric Inhibitory Polypeptide; Glucagon-Like Peptide 1; Glucose Tolerance Test; Humans; Immunosuppressive Agents; Incretins; Insulin; Kidney Transplantation; Tacrolimus | 2020 |
Clinical and genetic risk factors for new-onset diabetes mellitus after transplantation (NODAT) in major transplant centres in Malaysia.
Topics: Adult; Age Factors; Calcineurin Inhibitors; Cyclosporine; Diabetes Mellitus; Female; Genetic Predisposition to Disease; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Interleukin-7 Receptor alpha Subunit; Kidney Failure, Chronic; Kidney Transplantation; Malaysia; Male; Mannose-Binding Lectin; Middle Aged; Polymorphism, Single Nucleotide; Postoperative Complications; Proportional Hazards Models; Risk Factors; Survival Rate; Young Adult | 2020 |
Calcineurin inhibitor-associated new-onset diabetes mellitus in chronic kidney disease treatment: a 4-year single-center cross-sectional study in China.
Topics: Calcineurin Inhibitors; China; Cross-Sectional Studies; Cyclosporine; Diabetes Mellitus; Female; Glycated Hemoglobin; Humans; Logistic Models; Male; Middle Aged; Renal Insufficiency, Chronic; Retrospective Studies; Risk Factors; ROC Curve | 2021 |
New-Onset Diabetes After Transplantation: Comparison Between a Cyclosporine-Based and a Tacrolimus-Based Immunosuppressive Regimen.
Topics: Adult; Cyclosporine; Diabetes Mellitus; Female; Graft Rejection; Graft Survival; Humans; Immunocompromised Host; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Retrospective Studies; Tacrolimus; Transplant Recipients | 2018 |
Anti-Diabetogenic Properties of Mineralocorticoid Receptor Antagonists: Implications for Enhanced Safety and Efficacy of Post-Transplantation Pharmacotherapies.
Topics: Calcineurin; Calcineurin Inhibitors; Cyclosporine; Diabetes Complications; Diabetes Mellitus; Everolimus; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Mineralocorticoid Receptor Antagonists; Sirolimus; Spironolactone; Tacrolimus; Transplantation Tolerance | 2019 |
Risk factors for increased serum creatinine level in patients with psoriasis treated with cyclosporine in a real-world practice.
Topics: Adult; Age Factors; Aged; Creatinine; Cyclosporine; Diabetes Mellitus; Female; Humans; Immunosuppressive Agents; Kidney Diseases; Male; Middle Aged; Obesity; Psoriasis; Retrospective Studies; Risk Factors | 2019 |
Generalizable Protein Biosensors Based on Synthetic Switch Modules.
Topics: Acinetobacter calcoaceticus; alpha-Amylases; Amino Acid Sequence; Bacterial Proteins; Biomarkers; Biosensing Techniques; Calmodulin; Calmodulin-Binding Proteins; Cyclosporine; Diabetes Mellitus; Glucose Dehydrogenases; Humans; Protein Engineering; Recombinant Fusion Proteins; Saliva; Serum Albumin, Human; Tacrolimus; Tacrolimus Binding Proteins | 2019 |
New-onset diabetes after transplantation: assessment of risk factors and clinical outcomes.
Topics: Adult; Aged; Blood Glucose; Cyclosporine; Diabetes Mellitus; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Retrospective Studies; Risk Factors; Tacrolimus; Treatment Outcome | 2013 |
Post-transplant diabetes mellitus: is it associated with poor allograft outcomes in renal transplants?
Topics: Aged; Cyclosporine; Diabetes Mellitus; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Tacrolimus; Transplantation, Homologous; Treatment Outcome | 2013 |
Metabolic status of 1088 patients after renal transplantation: assessment of twelve years monitoring in Algiers Mustapha Hospital.
Topics: Adult; Algeria; Biomarkers; Blood Glucose; Chi-Square Distribution; Cyclosporine; Diabetes Mellitus; Drug Monitoring; Dyslipidemias; Female; Hospitals; Humans; Immunosuppressive Agents; Kidney; Kidney Transplantation; Lipids; Male; Middle Aged; Retrospective Studies; Tacrolimus; Time Factors; Treatment Outcome; Young Adult | 2014 |
Projecting long-term graft and patient survival after transplantation.
Topics: Abatacept; Adult; Clinical Trials, Phase III as Topic; Cyclosporine; Decision Support Techniques; Diabetes Mellitus; Female; Glomerular Filtration Rate; Graft Rejection; Graft Survival; Humans; Immunoconjugates; Immunosuppressive Agents; Kidney Transplantation; Male; Markov Chains; Models, Statistical; Outcome Assessment, Health Care; Randomized Controlled Trials as Topic; Survival Analysis; Survival Rate; Time Factors | 2014 |
A case report of improved metabolic control after conversion from everolimus to cyclosporin A: role of adipose tissue mechanisms?
Topics: Adipose Tissue; Aged; Cyclosporine; Diabetes Mellitus; Dyslipidemias; Everolimus; Female; Glucose; Humans; Immunosuppressive Agents; Kidney Transplantation; Sirolimus; TOR Serine-Threonine Kinases | 2014 |
Treatment of feline asthma with ciclosporin in a cat with diabetes mellitus and congestive heart failure.
Topics: Animals; Asthma; Cardiomyopathy, Hypertrophic; Cat Diseases; Cats; Cyclosporine; Diabetes Mellitus; Dose-Response Relationship, Drug; Heart Failure; Immunosuppressive Agents; Treatment Outcome | 2015 |
[Frequency of T-cell mediated rejection in new-onset diabetes after kidney transplantation].
Topics: Adult; Aged; Cyclosporine; Diabetes Mellitus; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Middle Aged; T-Lymphocytes; Tacrolimus | 2015 |
Liver injury correlates with biomarkers of autoimmunity and disease activity and represents an organ system involvement in patients with systemic lupus erythematosus.
Topics: Acetylcysteine; Adult; Alanine Transaminase; Antibodies, Antinuclear; Aspartate Aminotransferases; Azathioprine; Biomarkers; Cohort Studies; Complement System Proteins; Cyclosporine; Diabetes Mellitus; Female; Free Radical Scavengers; Humans; Immunosuppressive Agents; Liver Diseases; Longitudinal Studies; Lupus Erythematosus, Systemic; Male; Middle Aged; Mycophenolic Acid; Prednisone; Prevalence; Retrospective Studies; Severity of Illness Index; Sex Distribution; Sirolimus | 2015 |
Adiponectin and leptin gene polymorphisms in patients with post-transplant diabetes mellitus.
Topics: Adiponectin; Adult; Alleles; Cyclosporine; Diabetes Mellitus; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Leptin; Male; Middle Aged; Polymorphism, Genetic; Postoperative Complications; Risk; Tacrolimus | 2015 |
Is there a genetic predisposition to new-onset diabetes after kidney transplantation?
Topics: Adult; Calcineurin Inhibitors; Cyclosporine; Diabetes Mellitus; Female; Genetic Predisposition to Disease; Graft Rejection; HLA Antigens; Humans; Hyperglycemia; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Tacrolimus | 2015 |
Effect of interleukin-2 receptor antagonists on new-onset diabetes after liver transplantation: A retrospective cohort study.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Basiliximab; Cyclosporine; Daclizumab; Diabetes Mellitus; Female; Humans; Immunoglobulin G; Immunosuppressive Agents; Interleukin-2 Receptor alpha Subunit; Liver Transplantation; Male; Middle Aged; Outcome Assessment, Health Care; Proportional Hazards Models; Recombinant Fusion Proteins; Retrospective Studies; Risk Factors; Survival Analysis | 2016 |
CCL2 gene polymorphism is associated with post-transplant diabetes mellitus.
Topics: Calcineurin Inhibitors; Chemokine CCL2; Chemokine CCL5; Cyclosporine; Diabetes Mellitus; Female; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Kidney Transplantation; Male; Polymorphism, Single Nucleotide; Postoperative Complications; Tacrolimus | 2016 |
New-Onset Diabetes After Kidney Transplantation and Pretransplant Hypomagnesemia.
Topics: Adult; Age Factors; Body Mass Index; Cyclosporine; Diabetes Mellitus; Female; Graft Rejection; Humans; Immunosuppressive Agents; Insulin Resistance; Kidney Failure, Chronic; Kidney Transplantation; Magnesium; Male; Middle Aged; Mycophenolic Acid; Overweight; Retrospective Studies; Risk Factors; Tacrolimus; TOR Serine-Threonine Kinases; Water-Electrolyte Imbalance | 2016 |
Differential risks for adverse outcomes 3 years after kidney transplantation based on initial immunosuppression regimen: a national study.
Topics: Adolescent; Adult; Cyclosporine; Diabetes Mellitus; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Multivariate Analysis; Mycophenolic Acid; Pneumonia; Renal Insufficiency; Risk; Sepsis; Sirolimus; Tacrolimus; United States; Young Adult | 2016 |
Characteristics and risk profile of psoriasis patients included in the Czech national registry BIOREP and a comparison with other registries.
Topics: Acitretin; Adult; Biological Products; Body Mass Index; Comorbidity; Coronary Disease; Cyclosporine; Czech Republic; Dermatologic Agents; Diabetes Mellitus; Female; Humans; Hyperlipidemias; Hypertension; Keratolytic Agents; Male; Methotrexate; Middle Aged; Obesity; Phototherapy; Prevalence; Psoriasis; Quality of Life; Registries; Retreatment; Retrospective Studies; Risk Factors; Severity of Illness Index | 2017 |
Reduced exposure to calcineurin inhibitors in renal transplantation.
Topics: Calcineurin Inhibitors; Cyclosporine; Diabetes Mellitus; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid | 2008 |
Long-term graft outcome in patients with chronic allograft dysfunction after immunosuppression modifications.
Topics: Adult; Azathioprine; Cyclosporine; Diabetes Mellitus; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerular Filtration Rate; Graft Survival; Humans; Hyperlipidemias; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Mycophenolic Acid; Retrospective Studies; Tacrolimus; Transplantation, Homologous; Treatment Outcome | 2008 |
Factors associated with proteinuria in renal transplant recipients treated with sirolimus.
Topics: Acute Disease; Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Body Mass Index; Cyclosporine; Diabetes Mellitus; Drug Therapy, Combination; Female; Graft Rejection; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Kidney Transplantation; Lipids; Male; Middle Aged; Nephrons; Prevalence; Proteinuria; Sex Factors; Sirolimus; Vasoconstriction | 2009 |
Tacrolimus and angiotensin receptor blockers associated with changes in serum adiponectin level in new-onset diabetes after renal transplantation: single-center cross-sectional analysis.
Topics: Adiponectin; Adult; Angiotensin Receptor Antagonists; Cross-Sectional Studies; Cyclosporine; Diabetes Complications; Diabetes Mellitus; Female; Humans; Immunosuppressive Agents; Insulin Resistance; Kidney Transplantation; Male; Middle Aged; Risk Factors; Tacrolimus | 2009 |
Long-term renal function in liver transplant recipients and impact of immunosuppressive regimens (calcineurin inhibitors alone or in combination with mycophenolate mofetil): the TRY study.
Topics: Adolescent; Adult; Aged; Calcineurin Inhibitors; Cyclosporine; Diabetes Mellitus; Drug Therapy, Combination; Female; France; Glomerular Filtration Rate; Humans; Hypertension; Immunosuppressive Agents; Kidney; Linear Models; Liver Transplantation; Male; Middle Aged; Mycophenolic Acid; Renal Insufficiency; Retrospective Studies; Risk Assessment; Steroids; Tacrolimus; Time Factors; Treatment Outcome; Young Adult | 2009 |
Relationship between serum homocysteine and other parameters in renal transplant patients.
Topics: Azathioprine; Blood Pressure; Body Mass Index; C-Reactive Protein; Creatinine; Cross-Sectional Studies; Cyclosporine; Diabetes Mellitus; Female; Homocysteine; Humans; Hyperhomocysteinemia; Immunosuppressive Agents; Kidney Transplantation; Male | 2009 |
Rosiglitazone protects the pancreatic beta-cell death induced by cyclosporine A.
Topics: Animals; Cyclosporine; Cytoprotection; Diabetes Mellitus; Glucose Tolerance Test; Hypoglycemic Agents; Immunosuppressive Agents; Insulin; Insulin-Secreting Cells; Male; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones; Transplantation | 2009 |
Use of tacrolimus and the development of posttransplant diabetes mellitus: a Brazilian single-center, observational study.
Topics: Adolescent; Adult; Body Mass Index; Cyclosporine; Diabetes Mellitus; Female; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Living Donors; Male; Postoperative Complications; Retrospective Studies; Risk Factors; Sirolimus; Tacrolimus; Tissue Donors | 2010 |
A low-risk ZnT-8 allele (W325) for post-transplantation diabetes mellitus is protective against cyclosporin A-induced impairment of insulin secretion.
Topics: Alleles; Animals; Biomarkers, Pharmacological; Calcineurin Inhibitors; Cation Transport Proteins; Cell Line; Cyclosporine; Diabetes Mellitus; DNA-Binding Proteins; Glucose; Humans; Immunosuppressive Agents; Insulin; Insulin Secretion; Intracellular Signaling Peptides and Proteins; Kidney Transplantation; Mice; Muscle Proteins; Mutation; Rats; Zinc Transporter 8 | 2011 |
Antioxidant capacity in renal transplant patients.
Topics: Adult; Aged; Antioxidants; Benzothiazoles; Calibration; Chromans; Creatinine; Cyclosporine; Diabetes Mellitus; Female; Hematocrit; Humans; Immunosuppressive Agents; Indicators and Reagents; Kidney Function Tests; Kidney Transplantation; Male; Middle Aged; Sulfonic Acids; Young Adult | 2010 |
Triptolide prolonged allogeneic islet graft survival in chemically induced and spontaneously diabetic mice without impairment of islet function.
Topics: Animals; Blood Glucose; Cyclosporine; Diabetes Mellitus; Diabetes Mellitus, Experimental; Disease Models, Animal; Diterpenes; Epoxy Compounds; Female; Glucose Tolerance Test; Graft Rejection; Graft Survival; Immunosuppressive Agents; Islets of Langerhans; Islets of Langerhans Transplantation; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred NOD; Phenanthrenes; Time Factors; Transplantation, Homologous; Weight Gain | 2010 |
Phosphorylation of the CREB-specific coactivator TORC2 at Ser(307) regulates its intracellular localization in COS-7 cells and in the mouse liver.
Topics: Animals; Chlorocebus aethiops; COS Cells; Cyclic AMP Response Element-Binding Protein; Cyclosporine; Diabetes Mellitus; Enzyme Inhibitors; Insulin Resistance; Liver; Mice; Mice, Inbred C57BL; Mice, Obese; Mutagenesis, Site-Directed; Okadaic Acid; Phosphorylation; Protein Phosphatase 1; Protein Phosphatase 2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Serine; Trans-Activators; Transcription Factors | 2010 |
Endothelial nitric oxide synthase gene intron 4 polymorphism predicts new onset diabetes mellitus after transplantation in kidney allograft recipients treated with cyclosporin A.
Topics: Adolescent; Adult; Aged; Cyclosporine; Diabetes Mellitus; Female; Humans; Immunosuppressive Agents; Introns; Kidney Transplantation; Male; Middle Aged; Nitric Oxide Synthase Type III; Polymorphism, Genetic; Postoperative Complications; Young Adult | 2011 |
New-onset diabetes mellitus in kidney transplant recipients discharged on steroid-free immunosuppression.
Topics: Adult; Cohort Studies; Contraindications; Cyclosporine; Diabetes Mellitus; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Retrospective Studies; Risk Factors; Steroids; Tacrolimus | 2011 |
The long-term outcomes and costs of diabetes mellitus among renal transplant recipients: tacrolimus versus cyclosporine.
Topics: Adult; Aged; Cohort Studies; Cost-Benefit Analysis; Cyclosporine; Diabetes Mellitus; Female; Follow-Up Studies; Graft Rejection; Humans; Kidney Transplantation; Male; Middle Aged; Tacrolimus; Time Factors; Treatment Outcome; Young Adult | 2011 |
Functional and histopathologic changes in renal transplant patients with new-onset diabetes and dyslipidemia.
Topics: Adult; Analysis of Variance; Atrophy; Biomarkers; Biopsy; Body Mass Index; Case-Control Studies; Chi-Square Distribution; Creatinine; Cyclosporine; Diabetes Mellitus; Dyslipidemias; Female; Glomerular Filtration Rate; Glycated Hemoglobin; Graft Survival; Humans; Hungary; Immunosuppressive Agents; Kidney; Kidney Transplantation; Lipids; Logistic Models; Male; Middle Aged; Retrospective Studies; Risk Assessment; Risk Factors; Tacrolimus; Time Factors; Treatment Outcome | 2011 |
Side effects of cyclosporine-A treatment in rats: gingival overgrowth and early hyperglycemia.
Topics: Animals; Blood Glucose; Capillary Permeability; Collagen; Coloring Agents; Cyclosporine; Diabetes Mellitus; Evans Blue; Gingiva; Gingival Overgrowth; Hyperglycemia; Immunosuppressive Agents; Male; Nitric Oxide; Random Allocation; Rats; Rats, Wistar; Time Factors | 2010 |
The concentration of cyclosporine metabolites is significantly lower in kidney transplant recipients with diabetes mellitus.
Topics: Adult; Aged; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Cytochrome P-450 CYP3A; Diabetes Mellitus; Gene Expression Regulation; Genotype; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged | 2012 |
Arteriolar lesions in renal transplant biopsies: prevalence, progression, and clinical significance.
Topics: Adult; Age Factors; Aged; Arterioles; Biopsy; Cyclosporine; Diabetes Mellitus; Disease Progression; Female; Glomerular Filtration Rate; Humans; Hyalin; Hypertension; Immunosuppressive Agents; Kidney; Kidney Transplantation; Male; Middle Aged; Observer Variation; Reproducibility of Results; Retrospective Studies; Tacrolimus; Tissue Donors | 2012 |
New-onset diabetes mellitus in cyclosporine-treated organ transplant patients in Taiwan: interim analysis (6 months) of postmarketing surveillance.
Topics: Adult; Cyclosporine; Diabetes Mellitus; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Organ Transplantation; Product Surveillance, Postmarketing; Taiwan | 2012 |
Long-term follow-up after conversion from tacrolimus to cyclosporin in renal transplant patients with new-onset diabetes mellitus after transplantation.
Topics: Adult; Biomarkers; Blood Glucose; Calcineurin Inhibitors; Chronic Disease; Cyclosporine; Diabetes Mellitus; Drug Substitution; Female; Graft Rejection; Graft Survival; Humans; Hypoglycemic Agents; Immunosuppressive Agents; Kidney; Kidney Transplantation; Lipids; Male; Middle Aged; Retrospective Studies; Risk Factors; Tacrolimus; Time Factors; Treatment Outcome | 2012 |
Ticlopidine-induced marrow aplasia treated with cyclosporine.
Topics: Bone Marrow Diseases; Cyclosporine; Diabetes Complications; Diabetes Mellitus; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Ticlopidine; Treatment Outcome | 2002 |
Cardiovascular risk factors in liver allograft recipients: relationship with immunosuppressive therapy.
Topics: Adolescent; Adult; Aged; Body Weight; Cardiovascular Diseases; Creatinine; Cyclosporine; Diabetes Mellitus; Female; Humans; Hypercholesterolemia; Hypertension; Immunosuppressive Agents; Kidney Function Tests; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Prevalence; Retrospective Studies; Risk Factors; Tacrolimus; Transplantation, Homologous | 2002 |
Tacrolimus is associated with a lower incidence of cardiovascular complications in liver transplant recipients.
Topics: Adult; Cardiovascular Diseases; Creatinine; Cyclosporine; Diabetes Mellitus; Follow-Up Studies; Graft Rejection; Humans; Hyperlipidemias; Hypertension; Immunosuppressive Agents; Incidence; Liver Transplantation; Postoperative Complications; Retrospective Studies; Tacrolimus; Time Factors | 2002 |
Two-year outcome in renal allograft recipients comparing neoral-led with tacrolimus-led therapy.
Topics: Adolescent; Adult; Aged; Azathioprine; Creatinine; Cyclosporine; Diabetes Mellitus; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Humans; Incidence; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Postoperative Complications; Retrospective Studies; Tacrolimus; Time Factors; Transplantation, Homologous | 2002 |
Impact of immunosuppressive regimen on cardiovascular risk factors in kidney transplant recipients.
Topics: Cardiovascular Diseases; Creatinine; Cyclosporine; Diabetes Mellitus; Drug Therapy, Combination; Female; Humans; Hypertension; Immunosuppressive Agents; Kidney Transplantation; Male; Postoperative Complications; Retrospective Studies; Risk Factors; Sex Characteristics; Tacrolimus | 2002 |
Defining optimal immunosuppression for islet transplantation based on reduced diabetogenicity in canine islet autografts.
Topics: Animals; Cyclosporine; Diabetes Mellitus; Dogs; Dose-Response Relationship, Drug; Drug Therapy, Combination; Glucocorticoids; Immunosuppression Therapy; Immunosuppressive Agents; Islets of Langerhans; Islets of Langerhans Transplantation; Tacrolimus; Time Factors; Transplantation, Autologous | 2002 |
Cutaneous infection due to Scedosporium apiospermum in an immunosuppressed patient.
Topics: Antifungal Agents; Arthritis, Rheumatoid; Cyclosporine; Diabetes Mellitus; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Itraconazole; Middle Aged; Mycetoma; Scedosporium; Time Factors | 2003 |
[Treatment of diabetes mellitus in patients after renal transplantation].
Topics: Adult; Aged; Cyclosporine; Diabetes Mellitus; Female; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Poland; Sirolimus; Tacrolimus; Time Factors; Treatment Outcome | 2002 |
Influence of hypercholesterolemia on patient and graft survival in recipients of kidney transplants.
Topics: Adult; Age Factors; Cholesterol; Cyclosporine; Diabetes Mellitus; Female; Graft Survival; Humans; Hypercholesterolemia; Immunosuppressive Agents; Kidney Transplantation; Male; Retrospective Studies; Survival Analysis | 2003 |
Neuropsychologic side-effects of tacrolimus in pediatric renal transplantation.
Topics: Abdominal Pain; Adolescent; Aggression; Amenorrhea; Child; Child Behavior Disorders; Cyclosporine; Depression; Diabetes Mellitus; Drug Resistance; Female; Gingival Hyperplasia; Graft Rejection; Humans; Hypertrichosis; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Male; Sleep Initiation and Maintenance Disorders; Tacrolimus; Weight Loss | 2003 |
Incidence and cost of new onset diabetes mellitus among U.S. wait-listed and transplanted renal allograft recipients.
Topics: Calcineurin Inhibitors; Cyclosporine; Diabetes Mellitus; Graft Survival; Humans; Immunosuppressive Agents; Kidney; Kidney Transplantation; Multivariate Analysis; Peritoneal Dialysis; Regression Analysis; Renal Dialysis; Tacrolimus; Time Factors | 2003 |
Pediatric post-transplant diabetes: data from a large cohort of pediatric heart-transplant recipients.
Topics: Adolescent; Antilymphocyte Serum; Azathioprine; Child; Child, Preschool; Cohort Studies; Cyclosporine; Diabetes Mellitus; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Infant; Male; Retrospective Studies | 2003 |
Cardiovascular risk profile in nondiabetic renal transplant patients: cyclosporine versus tacrolimus.
Topics: Adult; Body Mass Index; Cardiovascular Diseases; Cholesterol; Cyclosporine; Diabetes Mellitus; Female; Humans; Hyperlipidemias; Hypertension; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Renal Replacement Therapy; Risk Factors; Tacrolimus | 2003 |
A comparison between cyclosporine and tacrolimus-based immunosuppression for renal allografts: renal function and blood pressure after 5 years.
Topics: Adult; Blood Pressure; Creatinine; Cyclosporine; Diabetes Mellitus; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Isoantibodies; Kidney Function Tests; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Tacrolimus; Time Factors | 2003 |
Diabetes mellitus after transplant: relationship to pretransplant glucose metabolism and tacrolimus or cyclosporine A-based therapy.
Topics: Adult; Antihypertensive Agents; Blood Glucose; Creatinine; Cyclosporine; Demography; Diabetes Mellitus; Female; Glucose Tolerance Test; Humans; Immunosuppressive Agents; Insulin Resistance; Kidney Diseases; Kidney Transplantation; Living Donors; Male; Patient Selection; Tacrolimus | 2003 |
Long-term outcome of kidney transplant using non-heart-beating donor: multicenter analysis of factors affecting graft survival.
Topics: Age Factors; Cadaver; Cyclosporine; Diabetes Mellitus; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Hyperlipidemias; Hypertension; Immunosuppressive Agents; Kidney Failure, Chronic; Retrospective Studies; Risk Factors; Tacrolimus; Time Factors; Tissue Donors | 2003 |
Analysis of survivors more than 10 years after heart transplantation in the cyclosporine era: Stanford experience.
Topics: Adult; Cohort Studies; Coronary Artery Disease; Cyclosporine; Diabetes Mellitus; Female; Graft Rejection; Heart Transplantation; Humans; Hyperlipidemias; Hypertension; Immunosuppressive Agents; Incidence; Male; Neoplasms; Registries; Renal Insufficiency; Survival Analysis; Survival Rate; Time Factors | 2004 |
Post-liver transplant acute renal failure: factors predicting development of end-stage renal disease.
Topics: Acute Kidney Injury; Creatinine; Cyclosporine; Diabetes Mellitus; Female; Follow-Up Studies; Humans; Hypertension; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Function Tests; Liver Transplantation; Logistic Models; Male; Middle Aged; Postoperative Complications; Risk Factors; Time Factors | 2004 |
Posttransplant diabetes mellitus in cyclosporine-treated renal allograft patients: a case-control study.
Topics: Adult; Case-Control Studies; Cyclosporine; Diabetes Mellitus; Humans; Immunosuppressive Agents; Kidney Transplantation; Middle Aged; Retrospective Studies; Transplantation, Homologous | 2004 |
Posttransplant diabetes mellitus in renal transplant patients with hepatitis C virus.
Topics: Adult; Brazil; Creatinine; Cyclosporine; Diabetes Mellitus; Female; Hepatitis C; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Prednisone; Racial Groups; Retrospective Studies; Tacrolimus | 2004 |
[Steroid-responsive nephrotic syndrome in IgA nephropathy].
Topics: Biopsy; Cyclophosphamide; Cyclosporine; Diabetes Mellitus; Drug Therapy, Combination; Glomerulonephritis, IGA; Humans; Immunosuppressive Agents; Male; Middle Aged; Nephrotic Syndrome; Osteoporosis; Prednisone; Proteinuria; Recurrence | 2004 |
[Association between diabetes mellitus and hepatitis C in kidney transplant patients].
Topics: Adult; Cyclosporine; Diabetes Mellitus; Female; Graft Survival; Hepacivirus; Hepatitis C; Hepatitis C Antibodies; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Multivariate Analysis; Odds Ratio; Postoperative Complications; Prevalence; Retrospective Studies | 2004 |
Maintenance immunosuppression use and the associated risk of avascular necrosis after kidney transplantation in the United States.
Topics: Adult; Cyclosporine; Diabetes Mellitus; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Lupus Erythematosus, Systemic; Male; Medicare; Middle Aged; Necrosis; Postoperative Complications; Regression Analysis; Sirolimus; Survival Analysis; United States | 2005 |
Rationale and design of the DIRECT study: a comparative assessment of the hyperglycemic effects of tacrolimus and cyclosporine following renal transplantation.
Topics: Adult; Aged; Cyclosporine; Diabetes Mellitus; Female; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Multicenter Studies as Topic; Postoperative Complications; Randomized Controlled Trials as Topic; Research Design; Survival Rate; Tacrolimus | 2005 |
Short-term rosiglitazone treatment in renal transplant recipients.
Topics: Cyclosporine; Diabetes Mellitus; Drug Administration Schedule; Humans; Hypoglycemic Agents; Immunosuppressive Agents; Insulin Resistance; Kidney Transplantation; Rosiglitazone; Tacrolimus; Thiazolidinediones | 2005 |
Factors influencing the onset of diabetes mellitus after kidney transplantation: a single French center experience.
Topics: Adult; Cyclosporine; Diabetes Mellitus; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Patient Selection; Postoperative Complications; Retrospective Studies; Tacrolimus | 2005 |
Conversion from tacrolimus to cyclosporin is associated with a significant improvement of glucose metabolism in patients with new-onset diabetes mellitus after renal transplantation.
Topics: Blood Glucose; Cyclosporine; Diabetes Mellitus; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Immunosuppressive Agents; Incidence; Insulin; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Reoperation; Retrospective Studies; Tacrolimus | 2005 |
New-onset diabetes after kidney transplantation: an application of 2003 International Guidelines.
Topics: Adult; Cyclosporine; Diabetes Mellitus; Female; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Middle Aged; Practice Guidelines as Topic; Risk Factors; Sirolimus; Tacrolimus | 2005 |
Posttransplant diabetes mellitus in kidney transplant recipients receiving calcineurin or mTOR inhibitor drugs.
Topics: Adult; Calcineurin Inhibitors; Cyclosporine; Diabetes Mellitus; Drug Therapy, Combination; Female; Glucocorticoids; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Protein Kinase Inhibitors; Protein Kinases; Risk Factors; Sirolimus; Tacrolimus; TOR Serine-Threonine Kinases | 2006 |
Conversion from tacrolimus to cyclosporine in liver transplanted patients with diabetes mellitus.
Topics: Adult; Aged; Blood Glucose; Cyclosporine; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Humans; Immunosuppression Therapy; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Tacrolimus; Treatment Outcome | 2006 |
Incidence of posttransplant diabetes mellitus in kidney transplant recipients immunosuppressed with sirolimus in combination with cyclosporine.
Topics: Adult; Cyclosporine; Diabetes Mellitus; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Immunosuppressive Agents; Incidence; Insulin; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Sirolimus | 2006 |
Diabetes mellitus after kidney transplantation: a French multicentre observational study.
Topics: Adult; Blood Glucose; Body Mass Index; Calcineurin Inhibitors; Cyclosporine; Diabetes Mellitus; Emulsions; Fasting; Female; France; Hepatitis C; Humans; Immunosuppressive Agents; Incidence; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Retrospective Studies; Risk Factors; Tacrolimus; Time Factors | 2007 |
Effect of various immunosuppressive monotherapies on survival and histopathology of monkey islet xenografts in rats.
Topics: Animals; Blood Glucose; Cyclosporine; Diabetes Mellitus; Graft Rejection; Graft Survival; Immunosuppression Therapy; Immunosuppressive Agents; Islets of Langerhans Transplantation; Macaca radiata; Prednisolone; Rats; Tacrolimus; Transplantation Tolerance; Transplantation, Heterologous | 2007 |
Influence of early posttransplantation prednisone and calcineurin inhibitor dosages on the incidence of new-onset diabetes.
Topics: Adult; Calcineurin Inhibitors; Cyclosporine; Diabetes Mellitus; Dose-Response Relationship, Drug; Glucocorticoids; Humans; Incidence; Kaplan-Meier Estimate; Kidney Transplantation; Middle Aged; Postoperative Care; Prednisone; Proportional Hazards Models; Risk Assessment; Tacrolimus | 2007 |
The combined effect of pre-transplant triglyceride levels and the type of calcineurin inhibitor in predicting the risk of new onset diabetes after renal transplantation.
Topics: Biomarkers; Calcineurin; Calcineurin Inhibitors; Cyclosporine; Diabetes Mellitus; Female; Follow-Up Studies; Glucocorticoids; Graft Rejection; Humans; Hypertriglyceridemia; Immunosuppressive Agents; Incidence; Insulin Resistance; Kidney Transplantation; Male; Methylprednisolone; Middle Aged; Prognosis; Retrospective Studies; Risk Factors; Spain; Tacrolimus; Time Factors; Triglycerides | 2008 |
Immunosuppressive medications, clinical and metabolic parameters in new-onset diabetes mellitus after kidney transplantation.
Topics: Adult; Blood Glucose; Body Mass Index; Cyclosporine; Diabetes Mellitus; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Multivariate Analysis; Risk Factors; Sirolimus; Tacrolimus; Triglycerides | 2008 |
Sirolimus is associated with new-onset diabetes in kidney transplant recipients.
Topics: Adult; Cyclosporine; Diabetes Mellitus; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Sirolimus; Tacrolimus | 2008 |
High incidence of posttransplant diabetes mellitus in renal transplant recipients on triple-drug immunosuppression.
Topics: Adult; Azathioprine; Chi-Square Distribution; Cyclosporine; Diabetes Mellitus; Drug Therapy, Combination; Female; Graft Rejection; Humans; Hypoglycemic Agents; Immunosuppressive Agents; Incidence; Insulin; Kidney Transplantation; Male; Postoperative Complications; Prednisolone; Retrospective Studies; Risk Factors | 1995 |
Functional aspects of mouse islets transplanted to the kidney.
Topics: Animals; Awards and Prizes; Cells, Cultured; Cyclosporine; Diabetes Mellitus; Europe; Glucose; Graft Survival; History, 20th Century; Insulin; Insulin Secretion; Islets of Langerhans Transplantation; Kidney; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred Strains; Societies, Medical; Sweden; Time Factors; Transplantation, Heterotopic; Transplantation, Isogeneic | 1994 |
Special management of diabetics, pregnant women, blacks, and children may enhance long-term organ transplant success.
Topics: Black or African American; Child; Cyclosporine; Diabetes Mellitus; Female; Humans; Immunosuppression Therapy; Pregnancy; Pregnancy Complications; Retrospective Studies; Transplantation Immunology; Treatment Outcome | 1994 |
Kidney transplantation in diabetic patients using cyclosporine. Five-year follow-up.
Topics: Actuarial Analysis; Boston; Cardiovascular Diseases; Cause of Death; Creatinine; Cyclosporine; Diabetes Mellitus; Diabetic Nephropathies; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Kidney Failure, Chronic; Kidney Transplantation; Middle Aged; Pancreas Transplantation; Retrospective Studies; Survival Rate; Tissue Donors; Treatment Outcome | 1995 |
Effects of steroid withdrawal on long-term renal allograft recipients with posttransplantation diabetes mellitus.
Topics: Adrenal Cortex Hormones; Adult; Body Weight; Cholesterol; Cyclosporine; Diabetes Mellitus; Female; Glucose; Humans; Hypertension; Kidney Transplantation; Lipoproteins, HDL; Male; Middle Aged; Prospective Studies; Transplantation, Homologous | 1994 |
Long-term side effects of cyclosporine-based immunosuppression in patients after liver transplantation.
Topics: Adolescent; Adult; Cyclosporine; Diabetes Mellitus; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Humans; Hypertension; Immunosuppression Therapy; Kidney; Kidney Diseases; Liver Transplantation; Prevalence; Retrospective Studies; Time Factors | 1994 |
Steroid-related complications in the cyclosporine era.
Topics: Adult; Age Factors; Bacterial Infections; Bone Diseases; Cataract; Cyclosporine; Diabetes Mellitus; Female; Follow-Up Studies; Gastrointestinal Diseases; Humans; Hypertension; Immunosuppression Therapy; Incidence; Joint Diseases; Kidney Transplantation; Male; Middle Aged; Multivariate Analysis; Mycoses; Osteonecrosis; Prednisone; Racial Groups; Sex Factors | 1994 |
Interaction between glipizide and cyclosporine: report of two cases.
Topics: Adult; Creatinine; Cyclosporine; Diabetes Mellitus; Drug Interactions; Glipizide; Glomerulonephritis, IGA; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged | 1993 |
Cyclosporine bioavailability: dosing implications and impact on clinical outcomes in select transplantation subpopulations.
Topics: Biological Availability; Black People; Cyclosporine; Diabetes Mellitus; Female; Graft Rejection; Humans; Immunosuppressive Agents; Organ Transplantation; Pregnancy; Treatment Outcome | 1996 |
Complete reversal of FK 506 induced diabetes in a liver transplant recipient by change of immunosuppression to cyclosporine A.
Topics: Adult; Blood Glucose; Cyclosporine; Diabetes Mellitus; Graft Rejection; Humans; Immunosuppressive Agents; Insulin; Liver; Liver Function Tests; Liver Transplantation; Male; Prognosis; Tacrolimus | 1996 |
Outcome of cadaveric renal transplantation by induction treatment in the cyclosporine era.
Topics: Adult; Antilymphocyte Serum; Cadaver; Creatinine; Cyclosporine; Diabetes Mellitus; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Histocompatibility; HLA Antigens; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Muromonab-CD3; Reoperation; T-Lymphocytes; Treatment Outcome | 1996 |
Metabolic problems in recipients of liver transplants.
Topics: Adult; Azathioprine; Carbohydrate Metabolism; Creatinine; Cyclosporine; Diabetes Mellitus; Female; Follow-Up Studies; Glucocorticoids; Humans; Hypercholesterolemia; Hypoglycemic Agents; Hypolipidemic Agents; Immunosuppressive Agents; Insulin; Liver Transplantation; Male; Prednisone; Proteinuria | 1996 |
Diabetes mellitus after liver transplantation: prevalence and predictive factors.
Topics: Adult; Aged; Cyclosporine; Diabetes Mellitus; Female; Humans; Liver Transplantation; Male; Middle Aged; Prevalence; Risk Factors | 1996 |
Possible interaction between cyclosporine and glibenclamide in posttransplant diabetic patients.
Topics: Adult; Cyclosporine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Diabetes Mellitus; Drug Interactions; Drug Therapy, Combination; Female; Glyburide; Humans; Hypoglycemic Agents; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mixed Function Oxygenases; Postoperative Complications | 1996 |
Gastric bypass in morbidly obese kidney transplant recipients.
Topics: Adult; Cyclosporine; Diabetes Mellitus; Female; Gastric Bypass; Humans; Hypertension; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Obesity, Morbid; Retrospective Studies; Weight Loss | 1996 |
Dilemma: maintenance therapy enhances sclerogenic risk profile.
Topics: Adult; Age Factors; Aged; Antihypertensive Agents; Arteriosclerosis; Azathioprine; Cholesterol; Cortisone; Cyclosporine; Diabetes Mellitus; Follow-Up Studies; Graft Rejection; Humans; Hypertension; Immunosuppressive Agents; Kidney Transplantation; Lipoproteins; Middle Aged; Postoperative Complications; Risk Factors; Time Factors; Triglycerides; Weight Gain | 1996 |
Cyclosporine and the renin-angiotensin axis.
Topics: Animals; Biopsy; Child; Cyclosporine; Diabetes Mellitus; Female; Humans; Hypertension; Kidney Glomerulus; Male; Middle Aged; Models, Theoretical; Renin; Renin-Angiotensin System | 1997 |
HLA-DQ matching in cadaveric renal transplantation.
Topics: Age Factors; Antibodies; Black People; Body Mass Index; Cadaver; Cold Temperature; Cyclosporine; Databases as Topic; Diabetes Mellitus; Female; Forecasting; Graft Survival; Histocompatibility; HLA-A Antigens; HLA-B Antigens; HLA-DQ Antigens; Humans; Immunosuppressive Agents; Kidney Transplantation; Life Tables; Male; Organ Preservation; Phenotype; Proportional Hazards Models; Sex Factors; Transplantation, Homologous; Treatment Outcome; White People | 1997 |
The impact of pre-transplant obesity on renal transplant outcomes.
Topics: Adult; Azathioprine; Body Mass Index; Cadaver; Cyclosporine; Diabetes Mellitus; Female; Glucocorticoids; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Male; Mycophenolic Acid; Obesity; Obesity, Morbid; Prednisone; Surgical Wound Infection; Survival Rate; Transplantation, Homologous; Treatment Outcome; Weight Gain | 1997 |
Evolution of cardiovascular risk after liver transplantation: a comparison of cyclosporine A and tacrolimus (FK506).
Topics: Adult; Benzothiadiazines; Blood Glucose; Blood Pressure; Body Weight; Cyclosporine; Diabetes Mellitus; Diuretics; Female; Humans; Hypercholesterolemia; Hypertension; Hypertriglyceridemia; Lipids; Liver Transplantation; Male; Middle Aged; Obesity; Prednisone; Risk Factors; Sex Factors; Sodium Chloride Symporter Inhibitors; Tacrolimus | 1997 |
Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age.
Topics: Adult; Age Factors; Cyclosporine; Diabetes Mellitus; Dose-Response Relationship, Drug; Family; Female; Glucose Intolerance; Graft Rejection; Histocompatibility Testing; HLA-B27 Antigen; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Methylprednisolone; Middle Aged; Postoperative Complications; Prednisolone; Prospective Studies; Risk Factors | 1997 |
Commentary on a comparison of tacrolimus and cyclosporine for immunosuppression after cadaveric renal transplantation.
Topics: Black People; Cyclosporine; Diabetes Mellitus; Graft Rejection; Graft Survival; Hispanic or Latino; Humans; Immunosuppressive Agents; Kidney Transplantation; Tacrolimus; White People | 1998 |
Effects of tacrolimus, mycophenolate mofetil, and cyclosporine microemulsion on rejection incidence in synchronous pancreas-kidney transplantation.
Topics: Adult; Cyclosporine; Diabetes Mellitus; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Mycophenolic Acid; Pancreas Transplantation; Tacrolimus; Transplantation, Homologous; Treatment Outcome | 1998 |
Metabolic effects of FK 506 (tacrolimus) versus cyclosporine in portally drained pancreas allografts.
Topics: Cyclosporine; Diabetes Complications; Diabetes Mellitus; Drainage; Female; Glucose; Graft Rejection; Humans; Hyperglycemia; Immunosuppressive Agents; Male; Pancreas Transplantation; Portal System; Tacrolimus; Transplantation, Homologous | 1998 |
Prevention of autoimmune destruction of syngeneic islet grafts in spontaneously diabetic nonobese diabetic mice by a combination of a vitamin D3 analog and cyclosporine.
Topics: Animals; Autoimmunity; Calcitriol; Calcium; Cholecalciferol; Cyclosporine; Diabetes Mellitus; Drug Combinations; Immunosuppressive Agents; Insulin; Islets of Langerhans; Islets of Langerhans Transplantation; Mice; Mice, Inbred NOD; Secondary Prevention; Transplantation, Isogeneic | 1998 |
Glipizide treatment of post-transplant diabetes does not interfere with cyclosporine pharmacokinetics in renal allograft recipients.
Topics: Adult; Aged; Cyclosporine; Diabetes Mellitus; Drug Interactions; Female; Glipizide; Humans; Hypoglycemic Agents; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Prospective Studies | 1998 |
The clinical status of cadaveric renal transplant patients treated for 10 year with cyclosporine therapy.
Topics: Adult; Cadaver; Creatinine; Cyclosporine; Diabetes Mellitus; Employment; Female; Follow-Up Studies; Graft Survival; Humans; Hypertension; Immunosuppressive Agents; Kidney Function Tests; Kidney Transplantation; Lipids; Male; Time Factors; Tissue Donors | 1999 |
Diabetes mellitus and liver transplantation in adults.
Topics: Adult; Aged; Azathioprine; Blood Glucose; Brazil; Cyclosporine; Diabetes Mellitus; Hepatitis C; Humans; Immunosuppressive Agents; Incidence; Liver Transplantation; Middle Aged; Postoperative Complications; Prednisone; Retrospective Studies | 1999 |
Diabetes mellitus in renal transplantation.
Topics: Adult; Aged; Cyclosporine; Diabetes Mellitus; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Proteinuria; Retrospective Studies; Time Factors | 1999 |
Risk factors for posttransplant diabetes mellitus and impact of this complication after renal transplantation.
Topics: Adult; Age Factors; Cyclosporine; Diabetes Mellitus; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Risk Factors; Tissue Donors | 2000 |
Conversion from tacrolimus to neoral for postrenal transplant diabetes.
Topics: Adrenal Cortex Hormones; Azathioprine; Child; Cyclosporine; Diabetes Mellitus; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Mycophenolic Acid; Postoperative Complications; Retrospective Studies; Tacrolimus | 2000 |
Post-transplant diabetes mellitus: increasing incidence in renal allograft recipients transplanted in recent years.
Topics: Adult; Cyclosporine; Diabetes Mellitus; Female; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Ohio; Time Factors; Transplantation, Homologous | 2001 |
High dose steroid regime: a tool for reducing organ rejection.
Topics: Adult; Azathioprine; Cyclosporine; Diabetes Mellitus; Female; Glucocorticoids; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Infections; Kidney Transplantation; Male; Methylprednisolone; Postoperative Complications; Retrospective Studies; Survival Rate | 2001 |
Strategies to minimize immunological and nonimmunological risk factors in the renal transplant population.
Topics: Cardiovascular Diseases; Child; Cyclosporine; Diabetes Mellitus; Graft Rejection; Humans; Hyperlipidemias; Hypertension; Immunosuppressive Agents; Kidney Transplantation; Ohio; Postoperative Complications; Risk Factors; Tacrolimus | 2001 |
High incidence of post-transplant diabetes mellitus in Kuwait.
Topics: Adult; Azathioprine; Cause of Death; Coronary Disease; Cyclosporine; Diabetes Mellitus; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Infections; Kidney Transplantation; Kuwait; Male; Middle Aged; Prednisone; Survival Rate | 2002 |
[Posttransplantation diabetes mellitus].
Topics: Adult; Aged; Cyclosporine; Diabetes Mellitus; Female; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged | 2000 |
Diabetes mellitus after renal transplantation.
Topics: Azathioprine; Creatinine; Cyclosporine; Diabetes Mellitus; Graft Rejection; Humans; Immunosuppression Therapy; Incidence; Kidney Transplantation; Prednisolone; Transplantation, Homologous | 1992 |
Postrenal transplant diabetes in conventional and cyclosporine regimens.
Topics: Blood Glucose; Cataract; Cyclosporine; Diabetes Mellitus; Graft Survival; Humans; Hyperglycemia; Hypertension; Kidney Transplantation | 1992 |
Posttransplant diabetes mellitus in renal allograft recipients.
Topics: Adolescent; Adult; Cadaver; Cyclosporine; Diabetes Mellitus; Diabetes Mellitus, Type 2; Female; Glucose Tolerance Test; Humans; Insulin; Kidney Transplantation; Male; Middle Aged; Postoperative Complications | 1992 |
[Problems and management in kidney transplant recipients with impaired glucose metabolism].
Topics: Azathioprine; Cyclosporine; Diabetes Mellitus; Glucose Tolerance Test; Graft Survival; Humans; Insulin; Kidney Failure, Chronic; Kidney Transplantation; Prognosis | 1992 |
Effects of cyclosporin A and low dosages of steroid on posttransplantation diabetes in kidney transplant recipients.
Topics: Azathioprine; Blood Glucose; Cyclosporine; Diabetes Mellitus; Glucose; Humans; Insulin; Kidney Transplantation; Methylprednisolone | 1991 |
Retrospective analysis of posttransplantation diabetes mellitus in black renal allograft recipients.
Topics: Adult; Black People; Cyclosporine; Diabetes Mellitus; Follow-Up Studies; Graft Survival; Humans; Kidney Transplantation; Prednisone; Retrospective Studies; Transplantation, Homologous; United States; Uremia | 1991 |